Abortion: Difference between revisions
No edit summary |
|||
(28 intermediate revisions by 2 users not shown) | |||
Line 7: | Line 7: | ||
==Overview== | ==Overview== | ||
Abortion is the [[Termination of pregnancy|termination]] of [[pregnancy]] before 20 weeks of [[gestation]], which was first described by an ancient Egyptian medical text as the Ebers Papyrus in 1550 BCE. Abortion is classified as threatened, complete, incomplete, inevitable, septic or missed. [[Chromosome abnormality|Chromosomal abnormalities]] is the most common [[Causes|cause]] of sporadic abortion that occur as early as 4-8 weeks [[gestation]], or it could be due to either [[infectious]], [[Immunological|immunologic]], and environmental factors. [[Fetal]] causes of abortion are [[Genetics|genetic]] or [[chromosomal abnormalities]] while maternal causes include age, [[antiphospholipid syndrome]], severe hypertension, or [[systemic lupus erythematosus]] ([[SLE]]). [[Risk factors]] for abortion include non-modifiable [[Risk factors|risk factor]]<nowiki/>s like advanced age >35 years and previous pregnancy loss. Modifiable [[risk factors]] include [[obesity]], [[infections]], acute and chronic stress, [[medication]] and [[Substance abuse|substance use]], [[cocaine]], [[alcohol]], [[tobacco]] and [[caffeine]]. [[Complications]] of abortion include [[infection]], post abortion traid, [[Uterine|uterine perforation]], [[Septic Shock|septic abortion]], [[Shock|cervical shock]], cervical [[laceration]], and [[Disseminated intravascular coagulation|disseminated intravascular coagulation (DIC)]]. The [[prognosis]] of abortion depends on the [[gestational age]]. The younger the [[gestational age]], the lower the risk of [[complications]]. | |||
==Historical Perspective== | ==Historical Perspective== | ||
*Abortion means termination of a [[pregnancy]] and it has been known since ancient times. | *Abortion means termination of a [[pregnancy]] and it has been known since ancient times. | ||
*Abortion was first | *Abortion was first described by an ancient Egyptian medical text as the Ebers Papyrus in 1550 BCE, which suggested that an abortion can be induced with the use of a plant-fiber [[tampon]] coated with honey and crushed dates.<ref name="urlThe Ancient History of Abortion and When it Began">{{cite web |url=https://www.thoughtco.com/when-did-abortion-begin-721090 |title=The Ancient History of Abortion and When it Began |format= |work= |accessdate=}}</ref> | ||
*During the ancient | *During the ancient Egyptian, Persian, and Roman eras, abortion was practiced although it was never explicitly mentioned in any book of the Judeo-Christian Bible.<ref name="urlThe Ancient History of Abortion and When it Began">{{cite web |url=https://www.thoughtco.com/when-did-abortion-begin-721090 |title=The Ancient History of Abortion and When it Began |format= |work= |accessdate=}}</ref> | ||
*In the fourth century BCE, Niddah 23a, a chapter of the Babylonian Talmud, | *In the fourth century BCE, Niddah 23a, a chapter of the Babylonian Talmud, reviews abortion as determining whether a woman is "unclean" and permitting abortion during early pregnancy.<ref name="urlThe Ancient History of Abortion and When it Began">{{cite web |url=https://www.thoughtco.com/when-did-abortion-begin-721090 |title=The Ancient History of Abortion and When it Began |format= |work= |accessdate=}}</ref> | ||
" A woman can only abort something in the shape of a stone, and that can only be described as a lump." | " A woman can only abort something in the shape of a stone, and that can only be described as a lump." | ||
* | *In 11th century BCE, the Code of Assura, <nowiki>'' a harsh set of laws restricting women in general''</nowiki> was the earliest legal ban on abortion by forcing the death penalty on married women who obtain abortions without permission of their husbands.<ref name="urlInternet History Sourcebooks">{{cite web |url=https://sourcebooks.fordham.edu/ancient/1075assyriancode.asp |title=Internet History Sourcebooks |format= |work= |accessdate=}}</ref> | ||
* | *In the fifth century BCE, the Hippocratic Oath prohibited physicians from inducing elective abortions.<ref name="urlThe Hippocratic Oath in Roe v. Wade | by Tara Mulder | EIDOLON">{{cite web |url=https://eidolon.pub/the-hippocratic-oath-in-roe-v-wade-ded59eedfd8f |title=The Hippocratic Oath in Roe v. Wade | by Tara Mulder | EIDOLON |format= |work= |accessdate=}}</ref> | ||
* | *In the 19th century, surgical abortions became common and Hegar dilator in 1879 invented dilation-and-curettage (D&C).<ref name="urlThe Ancient History of Abortion and When it Began4">{{cite web |url=https://www.thoughtco.com/when-did-abortion-begin-721090 |title=The Ancient History of Abortion and When it Began |format= |work= |accessdate=}}</ref> | ||
*On November 18,1920, the Commissariats of Health and Justice legalized abortion in Soviet hospitals.<ref name="urldocshare03.docshare.tips">{{cite web |url=http://docshare03.docshare.tips/files/28921/289218791.pdf |title=docshare03.docshare.tips |format= |work= |accessdate=}}</ref><ref name="Endres1971">{{cite journal|last1=Endres|first1=Richard J.|title=Abortion in perspective|journal=American Journal of Obstetrics and Gynecology|volume=111|issue=3|year=1971|pages=436–439|issn=00029378|doi=10.1016/0002-9378(71)90791-5}}</ref> | *On November 18, 1920, the Commissariats of Health and Justice legalized abortion in Soviet hospitals.<ref name="urldocshare03.docshare.tips">{{cite web |url=http://docshare03.docshare.tips/files/28921/289218791.pdf |title=docshare03.docshare.tips |format= |work= |accessdate=}}</ref><ref name="Endres1971">{{cite journal|last1=Endres|first1=Richard J.|title=Abortion in perspective|journal=American Journal of Obstetrics and Gynecology|volume=111|issue=3|year=1971|pages=436–439|issn=00029378|doi=10.1016/0002-9378(71)90791-5}}</ref> | ||
*In 1970, Hawaii, New York, Alaska and Washington declared their abortion laws. Hawaii was the first state to legalize abortions and New York allowed abortions up to the 24th week of pregnancy.<ref name="urldocshare03.docshare.tips2">{{cite web |url=http://docshare03.docshare.tips/files/28921/289218791.pdf |title=docshare03.docshare.tips |format= |work= |accessdate=}}</ref> | *In 1970, Hawaii, New York, Alaska and Washington declared their abortion laws. Hawaii was the first state to legalize abortions and New York allowed abortions up to the 24th week of pregnancy.<ref name="urldocshare03.docshare.tips2">{{cite web |url=http://docshare03.docshare.tips/files/28921/289218791.pdf |title=docshare03.docshare.tips |format= |work= |accessdate=}}</ref> | ||
Line 30: | Line 31: | ||
{| style="border: 0px; font-size: 90%; margin: 3px;" align="center" | {| style="border: 0px; font-size: 90%; margin: 3px;" align="center" | ||
! rowspan="1" style="background: #4479BA; padding: 5px 5px;" |{{fontcolor|#FFFFFF|Abortion type}} | ! rowspan="1" style="background: #4479BA; padding: 5px 5px;" |{{fontcolor|#FFFFFF|Abortion type}} | ||
! rowspan="1" style="background: #4479BA; padding: 5px 5px;" |{{fontcolor|#FFFFFF| | ! rowspan="1" style="background: #4479BA; padding: 5px 5px;" |{{fontcolor|#FFFFFF|Characteristics}} | ||
|- | |- | ||
| rowspan="1;" style="padding: 5px 5px; background: #DCDCDC; font-weight: bold;" |Early Threatened | | rowspan="1;" style="padding: 5px 5px; background: #DCDCDC; font-weight: bold;" |Early Threatened | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Abortion before 12 weeks gestation | | style="padding: 5px 5px; background: #F5F5F5;" |Abortion before 12 weeks [[gestation]] | ||
Symptoms: variable amount of bleeding | [[Symptoms]]: the variable amount of [[bleeding]] | ||
Cervix: closed | [[Cervix]]: closed | ||
Ultrasound: viable pregnancy | [[Ultrasound]]: viable [[pregnancy]] | ||
|- | |- | ||
| rowspan="1;" style="padding: 5px 5px; background: #DCDCDC; font-weight: bold;" |Late Inevitable | | rowspan="1;" style="padding: 5px 5px; background: #DCDCDC; font-weight: bold;" |Late Inevitable | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Abortion between 12 and 20 weeks gestation | | style="padding: 5px 5px; background: #F5F5F5;" |Abortion between 12 and 20 weeks [[gestation]] | ||
Symptoms: vaginal bleeding and abdominal pain | [[Symptoms]]: [[vaginal bleeding]] and [[abdominal pain]] | ||
Cervix:dilated/ open | [[Cervix]]:dilated/ open | ||
Ultrasound: product of conception seen at or above the cervix. | [[Ultrasound]]: product of [[conception]] seen at or above the [[cervix]]. | ||
|- | |- | ||
| rowspan="1;" style="padding: 5px 5px; background: #DCDCDC; font-weight: bold;" |Spontaneous | | rowspan="1;" style="padding: 5px 5px; background: #DCDCDC; font-weight: bold;" |Spontaneous | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" |Non-induced abortion | ||
|- | |- | ||
| rowspan="1;" style="padding: 5px 5px; background: #DCDCDC; font-weight: bold;" |Missed | | rowspan="1;" style="padding: 5px 5px; background: #DCDCDC; font-weight: bold;" |Missed | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Undetected death of an embryo or a fetus that is not expelled and that causes no bleeding (also called blighted ovum, anembryonic pregnancy, or intrauterine embryonic demise) | | style="padding: 5px 5px; background: #F5F5F5;" |Undetected death of an [[embryo]] or a [[fetus]] that is not expelled and that causes no [[bleeding]] (also called a blighted [[ovum]], [[Anembryonic gestation|anembryonic]] pregnancy, or [[Embryonic|intrauterine embryonic demise]]) | ||
Symptoms: variable, asymptomatic, light vaginal bleeding | [[Symptoms]]: variable, [[asymptomatic]], [[Vaginal bleeding|light vaginal bleeding]] | ||
Cervix: closed | [[Cervix]]: closed | ||
Ultrasound: Nonviable fetus | [[Ultrasound]]: Nonviable [[fetus]] | ||
|- | |- | ||
| rowspan="1;" style="padding: 5px 5px; background: #DCDCDC; font-weight: bold;" |Inevitable | | rowspan="1;" style="padding: 5px 5px; background: #DCDCDC; font-weight: bold;" |Inevitable | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Vaginal bleeding or rupture of the membranes accompanied by dilation of the cervix | | style="padding: 5px 5px; background: #F5F5F5;" |[[Vaginal bleeding]] or rupture of the [[membranes]] accompanied by dilation of the [[cervix]] | ||
Symptoms: Vaginal bleeding, uterine cramps, | [[Symptoms]]: [[Vaginal bleeding]], [[Uterine|uterine cramps]], | ||
Cervix: Open | [[Cervix]]: Open | ||
Ultrasound: Intrauterine fetus with possible heartbeats, ruptured or collapsed gestational sac | [[Ultrasound]]: Intrauterine fetus with possible heartbeats, ruptured or collapsed [[gestational sac]] | ||
|- | |- | ||
| rowspan="1;" style="padding: 5px 5px; background: #DCDCDC; font-weight: bold;" |Incomplete | | rowspan="1;" style="padding: 5px 5px; background: #DCDCDC; font-weight: bold;" |Incomplete | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Expulsion of some products of conception | | style="padding: 5px 5px; background: #F5F5F5;" |Expulsion of some products of [[conception]] | ||
Symptoms: Vaginal bleeding with large clots or tissue, uterine cramps, some products of conception can be visualized in the dilated cervical os | [[Symptoms]]: [[Vaginal bleeding]] with large clots or tissue, [[uterine]] cramps, some products of [[conception]] can be visualized in the [[Cervical os|dilated cervical os]] | ||
Cervix: Open | [[Cervix]]: Open | ||
Ultrasound: products of conception in the cervix | [[Ultrasound]]: products of [[conception]] in the [[cervix]] | ||
|- | |- | ||
| rowspan="1;" style="padding: 5px 5px; background: #DCDCDC; font-weight: bold;" |Threatened | | rowspan="1;" style="padding: 5px 5px; background: #DCDCDC; font-weight: bold;" |Threatened | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Vaginal bleeding occurring before 20 weeks gestation without cervical dilation and indicating that spontaneous abortion may occur | | style="padding: 5px 5px; background: #F5F5F5;" |[[Vaginal bleeding]] occurring before 20 weeks [[gestation]] without cervical dilation and indicating that [[Spontaneous abortions|spontaneous abortion]] may occur | ||
Symptoms: variable amount of bleeding | [[Symptom|Symptoms]]: the variable amount of [[bleeding]] | ||
Cervix: closed | [[Cervix]]: closed | ||
Ultrasound: viable pregnancy | [[Ultrasound]]: viable pregnancy | ||
|- | |- | ||
| rowspan="1;" style="padding: 5px 5px; background: #DCDCDC; font-weight: bold;" |Septic | | rowspan="1;" style="padding: 5px 5px; background: #DCDCDC; font-weight: bold;" |Septic | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Serious infection of the uterine contents during or shortly before or after an abortion. | | style="padding: 5px 5px; background: #F5F5F5;" |Serious [[infection]] of the [[uterine]] contents during or shortly before or after an abortion. Usually after induced abortion and rarely after [[spontaneous abortion]] | ||
Symptoms: | [[Symptoms]]: [[fever]], [[malaise]], signs of [[sepsis]], foul [[vaginal discharge]], [[cervical motion tenderness]], [[uterine]] tenderness, can be life-threatening | ||
Cervix: open | [[Cervix]]: open | ||
Ultrasound: retained products of conception | [[Ultrasound]]: retained products of [[conception]] | ||
|- | |- | ||
| rowspan="1;" style="padding: 5px 5px; background: #DCDCDC; font-weight: bold;" |Complete | | rowspan="1;" style="padding: 5px 5px; background: #DCDCDC; font-weight: bold;" |Complete | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Expulsion of all products of conception | | style="padding: 5px 5px; background: #F5F5F5;" |Expulsion of all products of [[conception]] | ||
Symptoms: variable, asymptomatic | [[Symptoms]]: variable, [[asymptomatic]] | ||
Cervix: closed, and the uterus should be contracted. | [[Cervix]]: closed, and the [[uterus]] should be contracted. | ||
Ultrasound: uterus is empty | [[Ultrasound]]: [[uterus]] is empty | ||
|- | |- | ||
| rowspan="1;" style="padding: 5px 5px; background: #DCDCDC; font-weight: bold;" |Recurrent or habitual | | rowspan="1;" style="padding: 5px 5px; background: #DCDCDC; font-weight: bold;" |Recurrent or habitual | ||
Line 103: | Line 104: | ||
|- | |- | ||
| rowspan="1;" style="padding: 5px 5px; background: #DCDCDC; font-weight: bold;" |Therapeutic | | rowspan="1;" style="padding: 5px 5px; background: #DCDCDC; font-weight: bold;" |Therapeutic | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Termination of pregnancy because the woman’s life or health is endangered or because the fetus is dead or has malformations incompatible with life.<br /> | | style="padding: 5px 5px; background: #F5F5F5;" |Termination of pregnancy because the woman’s life or health is endangered or because the [[fetus]] is dead or has malformations incompatible with life.<br /> | ||
|- | |- | ||
| rowspan="1;" style="padding: 5px 5px; background: #DCDCDC; font-weight: bold;" |Induced | | rowspan="1;" style="padding: 5px 5px; background: #DCDCDC; font-weight: bold;" |Induced | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Termination of pregnancy for medical or elective reasons | | style="padding: 5px 5px; background: #F5F5F5;" |Termination of [[pregnancy]] for medical or elective reasons | ||
|- | |- | ||
Line 114: | Line 115: | ||
==Pathophysiology== | ==Pathophysiology== | ||
*Chromosomal abnormalities is the most common cause of sporadic abortion that | *[[Chromosome abnormality|Chromosomal abnormalities]] is the most common cause of sporadic abortion that occurs as early as 4-8 weeks [[gestation]], for instance [[aneuploidy]], [[mosaicism]], [[translocation]], [[Inversion (kinesiology)|inversion]], [[Deletion (genetics)|deletion]], or fragile sites.<ref name="pmid11821293">{{cite journal| author=Stephenson MD, Awartani KA, Robinson WP| title=Cytogenetic analysis of miscarriages from couples with recurrent miscarriage: a case-control study. | journal=Hum Reprod | year= 2002 | volume= 17 | issue= 2 | pages= 446-51 | pmid=11821293 | doi=10.1093/humrep/17.2.446 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=11821293 }}</ref> | ||
*First-trimester pregnancy loss could be | *[[First trimester|First-trimester]] [[pregnancy loss]] could be due to either [[infectious]], [[Immunological|immunologic]], and [[Environmental factor|environmental]] factors. | ||
*Immunologic factors is not well defined. | *Immunologic factors is not well defined. Several theories suggest that [[Pregnancy loss|early pregnancy loss]] could be due to: <ref name="pmid12858110">{{cite journal| author=Kallen CB, Arici A| title=Immune testing in fertility practice: truth or deception? | journal=Curr Opin Obstet Gynecol | year= 2003 | volume= 15 | issue= 3 | pages= 225-31 | pmid=12858110 | doi=10.1097/00001703-200306000-00003 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=12858110 }}</ref><ref name="pmid10889838">{{cite journal| author=Hill JA, Choi BC| title=Maternal immunological aspects of pregnancy success and failure. | journal=J Reprod Fertil Suppl | year= 2000 | volume= 55 | issue= | pages= 91-7 | pmid=10889838 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=10889838 }}</ref> | ||
**Allogeneic factors. | **[[Allogeneic]] factors. | ||
** | **Lack of the immunological protection of the [[Embryo|embryos]], such as [[complement]] [[Regulatory protein|regulatory proteins]] (eg, [[Mannose-binding lectin pathway|mannose-binding lectin]], and [[HLA-DR]], [[HLA-G]] or [[HLA-E]]) | ||
**Increased | **Increased activity of [[uterine]] [[Natural killer cells|natural killer (uNK) cells]]. | ||
**Alloimmunization to blood group antigen P.<ref name="pmid17199881">{{cite journal| author=Hanafusa N, Noiri E, Yamashita T, Kondo Y, Suzuki M, Watanabe Y | display-authors=etal| title=Successful treatment by double filtrate plasmapheresis in a pregnant woman with the rare P blood group and a history of multiple early miscarriages. | journal=Ther Apher Dial | year= 2006 | volume= 10 | issue= 6 | pages= 498-503 | pmid=17199881 | doi=10.1111/j.1744-9987.2006.00393.x | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=17199881 }}</ref> | **[[Alloimmunization]] to [[blood]] group antigen P.<ref name="pmid17199881">{{cite journal| author=Hanafusa N, Noiri E, Yamashita T, Kondo Y, Suzuki M, Watanabe Y | display-authors=etal| title=Successful treatment by double filtrate plasmapheresis in a pregnant woman with the rare P blood group and a history of multiple early miscarriages. | journal=Ther Apher Dial | year= 2006 | volume= 10 | issue= 6 | pages= 498-503 | pmid=17199881 | doi=10.1111/j.1744-9987.2006.00393.x | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=17199881 }}</ref> | ||
*Anatomic distortion of uterus may be associated with early or second trimester pregnancy loss, eg: fibroids, polyps, adhesions, or septa depending on the size and position. | *Anatomic distortion of [[uterus]] may be associated with early or second [[trimester]] [[pregnancy loss]], eg: [[fibroids]], [[polyps]], [[adhesions]], or septa depending on the size and position. | ||
*The mechanism of pregnancy loss due to septate uterus is not clearly understood, one theory | *The mechanism of [[pregnancy loss]] due to [[septate uterus]] is not clearly understood, one theory suggests that poor blood supply to the septum leads to poor implantation.<ref name="pmid10632403">{{cite journal| author=Homer HA, Li TC, Cooke ID| title=The septate uterus: a review of management and reproductive outcome. | journal=Fertil Steril | year= 2000 | volume= 73 | issue= 1 | pages= 1-14 | pmid=10632403 | doi=10.1016/s0015-0282(99)00480-x | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=10632403 }}</ref> | ||
*FXIII and fibrinogen play an essential role in placental implantation and maintenance of pregnancy, that is why deficiency of factor XIII (FXIII) and fibrinogen are associated with pregnancy loss.<ref name="pmid12709920">{{cite journal| author=Inbal A, Muszbek L| title=Coagulation factor deficiencies and pregnancy loss. | journal=Semin Thromb Hemost | year= 2003 | volume= 29 | issue= 2 | pages= 171-4 | pmid=12709920 | doi=10.1055/s-2003-38832 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=12709920 }}</ref> | *[[Factor XIII|FXIII]] and [[fibrinogen]] play an essential role in [[placental]] [[implantation]] and maintenance of [[pregnancy]], that is why a deficiency of [[Factor XIII|factor XIII (FXIII)]] and [[fibrinogen]] are associated with [[pregnancy loss]].<ref name="pmid12709920">{{cite journal| author=Inbal A, Muszbek L| title=Coagulation factor deficiencies and pregnancy loss. | journal=Semin Thromb Hemost | year= 2003 | volume= 29 | issue= 2 | pages= 171-4 | pmid=12709920 | doi=10.1055/s-2003-38832 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=12709920 }}</ref> | ||
*It is thought that miscarriage risk is associated with low plasma levels of the hormone kisspeptin.<ref name="pmid25127195">{{cite journal| author=Jayasena CN, Abbara A, Izzi-Engbeaya C, Comninos AN, Harvey RA, Gonzalez Maffe J | display-authors=etal| title=Reduced levels of plasma kisspeptin during the antenatal booking visit are associated with increased risk of miscarriage. | journal=J Clin Endocrinol Metab | year= 2014 | volume= 99 | issue= 12 | pages= E2652-60 | pmid=25127195 | doi=10.1210/jc.2014-1953 | pmc=4255122 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=25127195 }}</ref> | *It is thought that [[Miscarriage risk factors|miscarriage risk]] is associated with low plasma levels of the [[Kisspeptin|hormone kisspeptin]].<ref name="pmid25127195">{{cite journal| author=Jayasena CN, Abbara A, Izzi-Engbeaya C, Comninos AN, Harvey RA, Gonzalez Maffe J | display-authors=etal| title=Reduced levels of plasma kisspeptin during the antenatal booking visit are associated with increased risk of miscarriage. | journal=J Clin Endocrinol Metab | year= 2014 | volume= 99 | issue= 12 | pages= E2652-60 | pmid=25127195 | doi=10.1210/jc.2014-1953 | pmc=4255122 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=25127195 }}</ref> | ||
*The mechanism of | *The mechanism of abortion in cases of [[Polycystic ovary syndrome|PCOS]] is unknown, however it could be related to elevated serum [[Luteinizing hormone|luteinizing hormone (LH)]] levels, high [[testosterone]] and [[androstenedione]] concentrations or [[insulin]] resistance<ref name="pmid12215322">{{cite journal| author=Craig LB, Ke RW, Kutteh WH| title=Increased prevalence of insulin resistance in women with a history of recurrent pregnancy loss. | journal=Fertil Steril | year= 2002 | volume= 78 | issue= 3 | pages= 487-90 | pmid=12215322 | doi=10.1016/s0015-0282(02)03247-8 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=12215322 }}</ref> | ||
<br /> | <br /> | ||
Line 132: | Line 133: | ||
'''Early Pregnancy Loss'''<ref name="pmid27842992">{{cite journal| author=Pereza N, Ostojić S, Kapović M, Peterlin B| title=Systematic review and meta-analysis of genetic association studies in idiopathic recurrent spontaneous abortion. | journal=Fertil Steril | year= 2017 | volume= 107 | issue= 1 | pages= 150-159.e2 | pmid=27842992 | doi=10.1016/j.fertnstert.2016.10.007 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=27842992 }}</ref><ref name="pmid29932168">{{cite journal| author=Barut MU, Bozkurt M, Kahraman M, Yıldırım E, Imirzalioğlu N, Kubar A | display-authors=etal| title=Thrombophilia and Recurrent Pregnancy Loss: The Enigma Continues. | journal=Med Sci Monit | year= 2018 | volume= 24 | issue= | pages= 4288-4294 | pmid=29932168 | doi=10.12659/MSM.908832 | pmc=6045916 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=29932168 }}</ref> | '''Early Pregnancy Loss'''<ref name="pmid27842992">{{cite journal| author=Pereza N, Ostojić S, Kapović M, Peterlin B| title=Systematic review and meta-analysis of genetic association studies in idiopathic recurrent spontaneous abortion. | journal=Fertil Steril | year= 2017 | volume= 107 | issue= 1 | pages= 150-159.e2 | pmid=27842992 | doi=10.1016/j.fertnstert.2016.10.007 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=27842992 }}</ref><ref name="pmid29932168">{{cite journal| author=Barut MU, Bozkurt M, Kahraman M, Yıldırım E, Imirzalioğlu N, Kubar A | display-authors=etal| title=Thrombophilia and Recurrent Pregnancy Loss: The Enigma Continues. | journal=Med Sci Monit | year= 2018 | volume= 24 | issue= | pages= 4288-4294 | pmid=29932168 | doi=10.12659/MSM.908832 | pmc=6045916 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=29932168 }}</ref> | ||
Fetal causes: | [[Fetal]] [[causes]]: | ||
*Genetic or chromosomal abnormalities (45,X karyotype, Trisomies (Trisomy 16 is the most common), aneuploidy, mosaicism, translocation, inversion, deletion, fragile sites) | *[[Genetics|Genetic]] or [[chromosomal abnormalities]] (45,X [[karyotype]], [[Trisomies]] ([[Trisomy 16]] is the most common), [[aneuploidy]], [[mosaicism]], [[translocation]], [[Inversion (kinesiology)|inversion]], [[Deletion (genetics)|deletion]], fragile sites) | ||
*Teratogenic and mutagenic factors | *[[Teratogenic]] and [[mutagenic]] factors. | ||
* | * | ||
Maternal causes: | [[Maternal]] [[causes]]: | ||
*Genetic: Maternal age is directly related to the aneuploidy risk, | *[[Genetics|Genetic]]: Maternal age is directly related to the [[aneuploidy]] risk, | ||
*Parental chromosomal anomaly balanced translocation | *Parental [[Chromosome abnormality|chromosomal anomaly]] [[balanced translocation]] | ||
*[[Corpus luteum|Corpus luteum deficiency]] | |||
*Active infection such as [[rubella virus]], [[cytomegalovirus]] | |||
* | *[[Antiphospholipid syndrome]] | ||
*[[Hypertensive crisis|Severe hypertension]] | |||
*[[Systemic lupus erythematosus|Systemic lupus erythematosus (SLE)]] | |||
*[[Renal disease]] | |||
*Poorly controlled [[diabetes mellitus]] | |||
*[[Polycystic ovary syndrome]] | |||
*Severe hypertension | |||
*Systemic lupus erythematosus (SLE) | |||
*Renal disease | |||
*Poorly controlled diabetes mellitus | |||
*Polycystic ovary syndrome | |||
==Differentiating abortion from other Diseases== | ==Differentiating abortion from other Diseases== | ||
Abortion should be differentiated from other causes of bleeding with cramping in early pregnancy:<ref name="urlMiscarriage - StatPearls - NCBI Bookshelf">{{cite web |url=https://www.ncbi.nlm.nih.gov/books/NBK532992/#!po=5.55556 |title=Miscarriage - StatPearls - NCBI Bookshelf |format= |work= |accessdate=}}</ref> | Abortion should be differentiated from other causes of [[bleeding]] with cramping in early [[pregnancy]]:<ref name="urlMiscarriage - StatPearls - NCBI Bookshelf">{{cite web |url=https://www.ncbi.nlm.nih.gov/books/NBK532992/#!po=5.55556 |title=Miscarriage - StatPearls - NCBI Bookshelf |format= |work= |accessdate=}}</ref> | ||
*Unrelated to pregnancy | *Related to [[Pregnancy]] | ||
**Infection (cervicitis) | **[[Ectopic pregnancy]] | ||
**Polyps | **[[Hematoma|Subchorionic hematoma]] | ||
**Fibroids | **[[Hydatidiform mole|Hydatidiform mole]] | ||
*Unrelated to [[pregnancy]] | |||
**[[Infection]] (cervicitis) | |||
**[[Polyps]] | |||
**[[Fibroids]] | |||
==Epidemiology and Demographics== | ==Epidemiology and Demographics== | ||
*The incidence of abortion | *The [[incidence]] of abortion worldwide was estimated to be 35 per 1,000 women ages 15 to 44 from 2010 to 2014.<ref name="pmid27179755">{{cite journal| author=Sedgh G, Bearak J, Singh S, Bankole A, Popinchalk A, Ganatra B | display-authors=etal| title=Abortion incidence between 1990 and 2014: global, regional, and subregional levels and trends. | journal=Lancet | year= 2016 | volume= 388 | issue= 10041 | pages= 258-67 | pmid=27179755 | doi=10.1016/S0140-6736(16)30380-4 | pmc=5498988 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=27179755 }}</ref> | ||
*The rate in resource-rich countries was 27 per | *The rate in resource-rich countries was 27 per 1,000 and in resource-limited countries was 37 per 1,000. The [[incidence]] was highest in the Caribbean (65 per 1,000), and the lowest in North America (17 per 1,000). <ref name="pmid28094905">{{cite journal| author=Jones RK, Jerman J| title=Abortion Incidence and Service Availability In the United States, 2014. | journal=Perspect Sex Reprod Health | year= 2017 | volume= 49 | issue= 1 | pages= 17-27 | pmid=28094905 | doi=10.1363/psrh.12015 | pmc=5487028 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=28094905 }}</ref> | ||
*In the United States, one in four women will have an abortion during their reproductive life.<ref name="pmid28094905" /> | *In the United States, one in four women will have an abortion during their [[reproductive]] life.<ref name="pmid28094905" /> | ||
*The [[incidence]] of abortion is approximately 31%, the true [[incidence]] of abortion is difficult to ascertain, as many losses are not recognized<ref name="pmid30894356">{{cite journal| author=Magnus MC, Wilcox AJ, Morken NH, Weinberg CR, Håberg SE| title=Role of maternal age and pregnancy history in risk of miscarriage: prospective register based study. | journal=BMJ | year= 2019 | volume= 364 | issue= | pages= l869 | pmid=30894356 | doi=10.1136/bmj.l869 | pmc=6425455 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=30894356 }}</ref><ref name="pmid33931702">{{cite journal| author=Wilcox AJ, Weinberg CR, O'Connor JF, Baird DD, Schlatterer JP, Canfield RE | display-authors=etal| title=Incidence of early loss of pregnancy. | journal=N Engl J Med | year= 1988 | volume= 319 | issue= 4 | pages= 189-94 | pmid=3393170 | doi=10.1056/NEJM198807283190401 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=3393170 }}</ref> | |||
*The incidence of abortion is approximately 31%, the true incidence of abortion is difficult to ascertain, as many losses are not recognized<ref name="pmid30894356">{{cite journal| author=Magnus MC, Wilcox AJ, Morken NH, Weinberg CR, Håberg SE| title=Role of maternal age and pregnancy history in risk of miscarriage: prospective register based study. | journal=BMJ | year= 2019 | volume= 364 | issue= | pages= l869 | pmid=30894356 | doi=10.1136/bmj.l869 | pmc=6425455 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=30894356 }}</ref><ref name="pmid33931702">{{cite journal| author=Wilcox AJ, Weinberg CR, O'Connor JF, Baird DD, Schlatterer JP, Canfield RE | display-authors=etal| title=Incidence of early loss of pregnancy. | journal=N Engl J Med | year= 1988 | volume= 319 | issue= 4 | pages= 189-94 | pmid=3393170 | doi=10.1056/NEJM198807283190401 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=3393170 }}</ref> | *The rate of abortion is influenced by maternal age and history of prior [[pregnancy loss]].<ref name="pmid308943562">{{cite journal| author=Magnus MC, Wilcox AJ, Morken NH, Weinberg CR, Håberg SE| title=Role of maternal age and pregnancy history in risk of miscarriage: prospective register based study. | journal=BMJ | year= 2019 | volume= 364 | issue= | pages= l869 | pmid=30894356 | doi=10.1136/bmj.l869 | pmc=6425455 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=30894356 }}</ref> 15% of women experience sporadic abortion, 2% of pregnant women experience two consecutive abortion and only 0.4 to 1% have three consecutive abortion. <ref name="pmid3073445">{{cite journal| author=Salat-Baroux J| title=[Recurrent spontaneous abortions]. | journal=Reprod Nutr Dev | year= 1988 | volume= 28 | issue= 6B | pages= 1555-68 | pmid=3073445 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=3073445 }}</ref> | ||
*The [[incidence]] of abortions in the United States were highest in women ages 20 to 24 (19.1 per 1,000 women) and 25 to 29 (18.5 per 1,000 women)<ref name="pmid33237897">{{cite journal| author=Kortsmit K, Jatlaoui TC, Mandel MG, Reeves JA, Oduyebo T, Petersen E | display-authors=etal| title=Abortion Surveillance - United States, 2018. | journal=MMWR Surveill Summ | year= 2020 | volume= 69 | issue= 7 | pages= 1-29 | pmid=33237897 | doi=10.15585/mmwr.ss6907a1 | pmc=7713711 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=33237897 }}</ref> | |||
*The rate of abortion influenced by maternal age and history of prior pregnancy loss.<ref name="pmid308943562">{{cite journal| author=Magnus MC, Wilcox AJ, Morken NH, Weinberg CR, Håberg SE| title=Role of maternal age and pregnancy history in risk of miscarriage: prospective register based study. | journal=BMJ | year= 2019 | volume= 364 | issue= | pages= l869 | pmid=30894356 | doi=10.1136/bmj.l869 | pmc=6425455 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=30894356 }}</ref> 15% of women experience sporadic abortion, 2% of pregnant women experience two consecutive abortion and only 0.4 to 1% have three consecutive abortion. <ref name="pmid3073445">{{cite journal| author=Salat-Baroux J| title=[Recurrent spontaneous abortions]. | journal=Reprod Nutr Dev | year= 1988 | volume= 28 | issue= 6B | pages= 1555-68 | pmid=3073445 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=3073445 }}</ref> | |||
*The incidence of | |||
*Most abortions were done in women who were unmarried (85%) and had one or more children (59%).<ref name="pmid33237897" /> | *Most abortions were done in women who were unmarried (85%) and had one or more children (59%).<ref name="pmid33237897" /> | ||
*Abortion rates in individuals of non-Hispanic White were 38.7 ,20.0 for Hispanic, and 7.7 for other races per | *Abortion rates in individuals of non-Hispanic White were 38.7, 20.0 for Hispanic, and 7.7 for other races per 1,000 women. <ref name="pmid33237897" /> | ||
*In the United States in 2018, 78% of abortions occur at 9 weeks or earlier, 92% at 13 weeks or earlier, and 8% at or after 14 weeks.<ref name="pmid332378972">{{cite journal| author=Kortsmit K, Jatlaoui TC, Mandel MG, Reeves JA, Oduyebo T, Petersen E | display-authors=etal| title=Abortion Surveillance - United States, 2018. | journal=MMWR Surveill Summ | year= 2020 | volume= 69 | issue= 7 | pages= 1-29 | pmid=33237897 | doi=10.15585/mmwr.ss6907a1 | pmc=7713711 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=33237897 }}</ref> | *In the United States in 2018, 78% of abortions occur at 9 weeks or earlier, 92% at 13 weeks or earlier, and 8% at or after 14 weeks.<ref name="pmid332378972">{{cite journal| author=Kortsmit K, Jatlaoui TC, Mandel MG, Reeves JA, Oduyebo T, Petersen E | display-authors=etal| title=Abortion Surveillance - United States, 2018. | journal=MMWR Surveill Summ | year= 2020 | volume= 69 | issue= 7 | pages= 1-29 | pmid=33237897 | doi=10.15585/mmwr.ss6907a1 | pmc=7713711 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=33237897 }}</ref> | ||
==Risk Factors== | ==Risk Factors== | ||
'''Non-modifiable risk | '''Non-modifiable [[risk factors]] include''': <ref name="pmid30400160">{{cite journal| author=Hu X, Miao M, Bai Y, Cheng N, Ren X| title=Reproductive Factors and Risk of Spontaneous Abortion in the Jinchang Cohort. | journal=Int J Environ Res Public Health | year= 2018 | volume= 15 | issue= 11 | pages= | pmid=30400160 | doi=10.3390/ijerph15112444 | pmc=6266092 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=30400160 }}</ref> | ||
*Advanced age >35 years the most significant risk factor because of the associated fetal chromosomal abnormalities. | *Advanced age >35 years, the most significant risk factor because of the associated fetal [[chromosomal abnormalities]]. | ||
*Extremes of age | *Extremes of age | ||
*Advanced paternal age | *Advanced paternal age | ||
*Previous pregnancy loss | *Previous [[pregnancy loss]] increases the risk of later [[pregnancy loss]].<ref name="pmid308943563">{{cite journal| author=Magnus MC, Wilcox AJ, Morken NH, Weinberg CR, Håberg SE| title=Role of maternal age and pregnancy history in risk of miscarriage: prospective register based study. | journal=BMJ | year= 2019 | volume= 364 | issue= | pages= l869 | pmid=30894356 | doi=10.1136/bmj.l869 | pmc=6425455 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=30894356 }}</ref> | ||
''' | '''Modifiable [[risk factors]] include:''' | ||
* | *[[Obesity]]<ref name="pmid18068166">{{cite journal| author=Metwally M, Ong KJ, Ledger WL, Li TC| title=Does high body mass index increase the risk of miscarriage after spontaneous and assisted conception? A meta-analysis of the evidence. | journal=Fertil Steril | year= 2008 | volume= 90 | issue= 3 | pages= 714-26 | pmid=18068166 | doi=10.1016/j.fertnstert.2007.07.1290 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=18068166 }}</ref> | ||
*Infection (eg: Parvovirus B19 infection,syphilis, cytomegalovirus (CMV) infection)<ref name="pmid29628283">{{cite journal| author=Frazier T, Hogue CJR, Bonney EA, Yount KM, Pearce BD| title=Weathering the storm; a review of pre-pregnancy stress and risk of spontaneous abortion. | journal=Psychoneuroendocrinology | year= 2018 | volume= 92 | issue= | pages= 142-154 | pmid=29628283 | doi=10.1016/j.psyneuen.2018.03.001 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=29628283 }}</ref><ref name="pmid26499091">{{cite journal| author=Rasti S, Ghasemi FS, Abdoli A, Piroozmand A, Mousavi SG, Fakhrie-Kashan Z| title=ToRCH "co-infections" are associated with increased risk of abortion in pregnant women. | journal=Congenit Anom (Kyoto) | year= 2016 | volume= 56 | issue= 2 | pages= 73-8 | pmid=26499091 | doi=10.1111/cga.12138 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=26499091 }}</ref><ref name="pmid23476094">{{cite journal| author=Gomez GB, Kamb ML, Newman LM, Mark J, Broutet N, Hawkes SJ| title=Untreated maternal syphilis and adverse outcomes of pregnancy: a systematic review and meta-analysis. | journal=Bull World Health Organ | year= 2013 | volume= 91 | issue= 3 | pages= 217-26 | pmid=23476094 | doi=10.2471/BLT.12.107623 | pmc=3590617 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23476094 }}</ref> | *[[Infection]] (eg: [[Parvovirus B19]] infection,[[syphilis]], [[Cytomegalovirus infection|cytomegalovirus (CMV) infection]])<ref name="pmid29628283">{{cite journal| author=Frazier T, Hogue CJR, Bonney EA, Yount KM, Pearce BD| title=Weathering the storm; a review of pre-pregnancy stress and risk of spontaneous abortion. | journal=Psychoneuroendocrinology | year= 2018 | volume= 92 | issue= | pages= 142-154 | pmid=29628283 | doi=10.1016/j.psyneuen.2018.03.001 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=29628283 }}</ref><ref name="pmid26499091">{{cite journal| author=Rasti S, Ghasemi FS, Abdoli A, Piroozmand A, Mousavi SG, Fakhrie-Kashan Z| title=ToRCH "co-infections" are associated with increased risk of abortion in pregnant women. | journal=Congenit Anom (Kyoto) | year= 2016 | volume= 56 | issue= 2 | pages= 73-8 | pmid=26499091 | doi=10.1111/cga.12138 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=26499091 }}</ref><ref name="pmid23476094">{{cite journal| author=Gomez GB, Kamb ML, Newman LM, Mark J, Broutet N, Hawkes SJ| title=Untreated maternal syphilis and adverse outcomes of pregnancy: a systematic review and meta-analysis. | journal=Bull World Health Organ | year= 2013 | volume= 91 | issue= 3 | pages= 217-26 | pmid=23476094 | doi=10.2471/BLT.12.107623 | pmc=3590617 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23476094 }}</ref> | ||
* | *Pre-gestational [[diabetes]] increases the risk of miscarriage two- to threefold.<ref name="pmid24292565">{{cite journal| author=Tennant PW, Glinianaia SV, Bilous RW, Rankin J, Bell R| title=Pre-existing diabetes, maternal glycated haemoglobin, and the risks of fetal and infant death: a population-based study. | journal=Diabetologia | year= 2014 | volume= 57 | issue= 2 | pages= 285-94 | pmid=24292565 | doi=10.1007/s00125-013-3108-5 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24292565 }}</ref> | ||
* | *Hyper- and [[hypothyroidism]] <ref name="pmid26837268">{{cite journal| author=Maraka S, Ospina NM, O'Keeffe DT, Espinosa De Ycaza AE, Gionfriddo MR, Erwin PJ | display-authors=etal| title=Subclinical Hypothyroidism in Pregnancy: A Systematic Review and Meta-Analysis. | journal=Thyroid | year= 2016 | volume= 26 | issue= 4 | pages= 580-90 | pmid=26837268 | doi=10.1089/thy.2015.0418 | pmc=4827301 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=26837268 }}</ref> | ||
*Acute and chronic stress<ref name="pmid29530382">{{cite journal| author=Li Y, Margerison-Zilko C, Strutz KL, Holzman C| title=Life Course Adversity and Prior Miscarriage in a Pregnancy Cohort. | journal=Womens Health Issues | year= 2018 | volume= 28 | issue= 3 | pages= 232-238 | pmid=29530382 | doi=10.1016/j.whi.2018.02.001 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=29530382 }}</ref> | *Acute and chronic stress<ref name="pmid29530382">{{cite journal| author=Li Y, Margerison-Zilko C, Strutz KL, Holzman C| title=Life Course Adversity and Prior Miscarriage in a Pregnancy Cohort. | journal=Womens Health Issues | year= 2018 | volume= 28 | issue= 3 | pages= 232-238 | pmid=29530382 | doi=10.1016/j.whi.2018.02.001 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=29530382 }}</ref> | ||
*Medication and substance use, | *[[Medication]] and substance use, examples are [[non-steroidal anti-inflammatory drug|NSAIDs]] ([[ibuprofen]] and [[diclofenac]]), [[cocaine]], [[methamphetamines]]<ref name="pmid21896698">{{cite journal| author=Nakhai-Pour HR, Broy P, Sheehy O, Bérard A| title=Use of nonaspirin nonsteroidal anti-inflammatory drugs during pregnancy and the risk of spontaneous abortion. | journal=CMAJ | year= 2011 | volume= 183 | issue= 15 | pages= 1713-20 | pmid=21896698 | doi=10.1503/cmaj.110454 | pmc=3193112 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21896698 }} [https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=&cmd=prlinks&id=22411163 Review in: Evid Based Nurs. 2012 Jul;15(3):76-7]</ref> | ||
*Alcohol, tobacco and caffeine<ref name="pmid24810392">{{cite journal| author=Avalos LA, Roberts SC, Kaskutas LA, Block G, Li DK| title=Volume and type of alcohol during early pregnancy and the risk of miscarriage. | journal=Subst Use Misuse | year= 2014 | volume= 49 | issue= 11 | pages= 1437-45 | pmid=24810392 | doi=10.3109/10826084.2014.912228 | pmc=4183196 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24810392 }}</ref><ref name="pmid9929522">{{cite journal| author=Ness RB, Grisso JA, Hirschinger N, Markovic N, Shaw LM, Day NL | display-authors=etal| title=Cocaine and tobacco use and the risk of spontaneous abortion. | journal=N Engl J Med | year= 1999 | volume= 340 | issue= 5 | pages= 333-9 | pmid=9929522 | doi=10.1056/NEJM199902043400501 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=9929522 }}</ref><ref name="pmid26329421">{{cite journal| author=Chen LW, Wu Y, Neelakantan N, Chong MF, Pan A, van Dam RM| title=Maternal caffeine intake during pregnancy and risk of pregnancy loss: a categorical and dose-response meta-analysis of prospective studies. | journal=Public Health Nutr | year= 2016 | volume= 19 | issue= 7 | pages= 1233-44 | pmid=26329421 | doi=10.1017/S1368980015002463 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=26329421 }}</ref><ref name="pmid29739005">{{cite journal| author=Lee SW, Han YJ, Cho DH, Kwak HS, Ko K, Park MH | display-authors=etal| title=Smoking Exposure in Early Pregnancy and Adverse Pregnancy Outcomes: Usefulness of Urinary Tobacco-Specific Nitrosamine Metabolite 4-(Methylnitrosamino)-1-(3-Pyridyl)-1-Butanol Levels. | journal=Gynecol Obstet Invest | year= 2018 | volume= 83 | issue= 4 | pages= 365-374 | pmid=29739005 | doi=10.1159/000485617 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=29739005 }}</ref> | *[[Alcohol]], [[tobacco]] and [[caffeine]]<ref name="pmid24810392">{{cite journal| author=Avalos LA, Roberts SC, Kaskutas LA, Block G, Li DK| title=Volume and type of alcohol during early pregnancy and the risk of miscarriage. | journal=Subst Use Misuse | year= 2014 | volume= 49 | issue= 11 | pages= 1437-45 | pmid=24810392 | doi=10.3109/10826084.2014.912228 | pmc=4183196 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24810392 }}</ref><ref name="pmid9929522">{{cite journal| author=Ness RB, Grisso JA, Hirschinger N, Markovic N, Shaw LM, Day NL | display-authors=etal| title=Cocaine and tobacco use and the risk of spontaneous abortion. | journal=N Engl J Med | year= 1999 | volume= 340 | issue= 5 | pages= 333-9 | pmid=9929522 | doi=10.1056/NEJM199902043400501 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=9929522 }}</ref><ref name="pmid26329421">{{cite journal| author=Chen LW, Wu Y, Neelakantan N, Chong MF, Pan A, van Dam RM| title=Maternal caffeine intake during pregnancy and risk of pregnancy loss: a categorical and dose-response meta-analysis of prospective studies. | journal=Public Health Nutr | year= 2016 | volume= 19 | issue= 7 | pages= 1233-44 | pmid=26329421 | doi=10.1017/S1368980015002463 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=26329421 }}</ref><ref name="pmid29739005">{{cite journal| author=Lee SW, Han YJ, Cho DH, Kwak HS, Ko K, Park MH | display-authors=etal| title=Smoking Exposure in Early Pregnancy and Adverse Pregnancy Outcomes: Usefulness of Urinary Tobacco-Specific Nitrosamine Metabolite 4-(Methylnitrosamino)-1-(3-Pyridyl)-1-Butanol Levels. | journal=Gynecol Obstet Invest | year= 2018 | volume= 83 | issue= 4 | pages= 365-374 | pmid=29739005 | doi=10.1159/000485617 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=29739005 }}</ref> | ||
==Screening== | ==Screening== | ||
There is insufficient evidence to recommend routine screening for | There is insufficient evidence to recommend routine screening for abortion. | ||
==Natural History, Complications, and Prognosis== | ==Natural History, Complications, and Prognosis== | ||
*Complications of spontaneous abortion and therapeutic abortions include the following:<ref name="pmid24962349">{{cite journal| author=Lim LM, Singh K| title=Termination of pregnancy and unsafe abortion. | journal=Best Pract Res Clin Obstet Gynaecol | year= 2014 | volume= 28 | issue= 6 | pages= 859-69 | pmid=24962349 | doi=10.1016/j.bpobgyn.2014.05.005 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24962349 }}</ref> | |||
**[[Complications]] of [[anesthesia]] | |||
**Post abortion triad ([[pain]], [[bleeding]], [[low-grade fever]]) caused by retained products of [[conception]]. | |||
**Retained products of [[conception]] | |||
**[[Uterine|Uterine perforation]]<ref name="pmid22048784">{{cite journal| author=Koshiba A, Koshiba H, Noguchi T, Iwasaku K, Kitawaki J| title=Uterine perforation with omentum incarceration after dilatation and evacuation/curettage: magnetic resonance imaging findings. | journal=Arch Gynecol Obstet | year= 2012 | volume= 285 | issue= 3 | pages= 887-90 | pmid=22048784 | doi=10.1007/s00404-011-2127-z | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=22048784 }}</ref> | |||
**[[Septic Shock|Septic abortion]]<ref name="pmid20046250">{{cite journal| author=Saultes TA, Devita D, Heiner JD| title=The back alley revisited: sepsis after attempted self-induced abortion. | journal=West J Emerg Med | year= 2009 | volume= 10 | issue= 4 | pages= 278-80 | pmid=20046250 | doi= | pmc=2791734 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20046250 }}</ref> | |||
**[[Shock|Cervical shock]] | |||
**Cervical [[laceration]] | |||
**[[Disseminated intravascular coagulation|Disseminated intravascular coagulation (DIC)]] | |||
*Prognosis of abortion depends on the [[gestational age]]. The younger the [[gestational age]], the lower the risk of [[complications]]. The highest risk of death is from a [[Septic Shock|septic abortion]]; the majority of these cases are a result of illegal abortions in developing countries.<ref name="urlMiscarriage - StatPearls - NCBI Bookshelf2">{{cite web |url=https://www.ncbi.nlm.nih.gov/books/NBK532992/#!po=5.55556 |title=Miscarriage - StatPearls - NCBI Bookshelf |format= |work= |accessdate=}}</ref> | |||
==Diagnosis== | ==Diagnosis== | ||
===Diagnostic Study of Choice=== | ===Diagnostic Study of Choice=== | ||
*Ultrasound shows no intrauterine pregnancy or loss of previously seen cardiac activity is diagnostic if the intrauterine pregnancy is confirmed by ultrasound in a previous visit.<ref name="urlUpToDate">{{cite web |url=https://www.uptodate.com/contents/pregnancy-loss-miscarriage-risk-factors-etiology-clinical-manifestations-and-diagnostic-evaluation?search=miscarriage&source=search_result&selectedTitle=2~150&usage_type=default&display_rank=2#H3674675200 |title=UpToDate |format= |work= |accessdate=}}</ref> | *[[Ultrasound]] shows no intrauterine [[pregnancy]] or loss of previously seen [[Cardiac|cardiac activity]] is diagnostic if the intrauterine [[pregnancy]] is confirmed by [[ultrasound]] in a previous visit.<ref name="urlUpToDate">{{cite web |url=https://www.uptodate.com/contents/pregnancy-loss-miscarriage-risk-factors-etiology-clinical-manifestations-and-diagnostic-evaluation?search=miscarriage&source=search_result&selectedTitle=2~150&usage_type=default&display_rank=2#H3674675200 |title=UpToDate |format= |work= |accessdate=}}</ref> | ||
*The diagnosis of early pregnancy loss (EPL) if the initial transvaginal ultrasound shows intrauterine pregnancy without fetal cardiac activity is based on the | *The diagnosis of early pregnancy loss (EPL) occurs if the initial transvaginal ultrasound shows intrauterine pregnancy without [[Fetal circulation|fetal]] [[cardiac]] activity and is based on the criteria made by the Society of Radiologists in Ultrasound Multi-specialty Panel on Early First Trimester [[Diagnosis]] of [[Miscarriage]] and Exclusion of a Viable Intrauterine [[Pregnancy]], which include:<ref name="pmid24106937">{{cite journal| author=Doubilet PM, Benson CB, Bourne T, Blaivas M, Society of Radiologists in Ultrasound Multispecialty Panel on Early First Trimester Diagnosis of Miscarriage and Exclusion of a Viable Intrauterine Pregnancy. Barnhart KT | display-authors=etal| title=Diagnostic criteria for nonviable pregnancy early in the first trimester. | journal=N Engl J Med | year= 2013 | volume= 369 | issue= 15 | pages= 1443-51 | pmid=24106937 | doi=10.1056/NEJMra1302417 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24106937 }}</ref> | ||
**A gestational sac ≥25 mm in mean diameter that does not contain a yolk sac or embryo | **A [[gestational sac]] ≥25 mm in mean diameter that does not contain a [[yolk sac]] or [[embryo]] | ||
**An embryo with a crown-rump length (CRL) ≥7 mm that does not have cardiac activity | **An [[embryo]] with a crown-rump length (CRL) ≥7 mm that does not have [[cardiac]] activity | ||
**After a pelvic ultrasound | **After a [[Pelvis|pelvic]] [[ultrasound]] shows a gestational sac without a [[yolk sac]], absence of an [[embryo]] with a [[heartbeat]] in ≥2 weeks | ||
**After a pelvic ultrasound | **After a [[Pelvis|pelvic]] [[ultrasound]] shows a [[gestational sac]] with a [[yolk sac]], absence of an [[embryo]] with a [[heartbeat]] in ≥11 days | ||
**Findings that are suspicious for, but not diagnostic of, pregnancy loss include: | **Findings that are suspicious for, but not [[diagnostic]] of, [[pregnancy loss]] include: | ||
***CRL <7 mm and no heartbeat. | ***CRL <7 mm and no [[heartbeat]]. | ||
***Mean sac diameter of 16 to 24 mm and no embryo. | ***Mean sac diameter of 16 to 24 mm and no [[embryo]]. | ||
***Absence of embryo with a heartbeat 7 to 13 days after a scan that showed a gestational sac without a yolk sac | ***Absence of [[embryo]] with a [[heartbeat]] 7 to 13 days after a [[scan]] that showed a [[gestational sac]] without a [[yolk sac]] | ||
***Absence of embryo with a heartbeat 7 to 10 days after a scan that showed a gestational sac with a yolk sac | ***Absence of [[embryo]] with a heartbeat 7 to 10 days after a scan that showed a [[gestational sac]] with a [[yolk sac]] | ||
***Absence of embryo ≥6 weeks after last menstrual period | ***Absence of [[embryo]] ≥6 weeks after [[Menstrual cycle|last menstrual period]] | ||
***Empty amnion (amnion seen adjacent to yolk sac with no visible embryo) | ***[[Amnion|Empty amnion]] (amnion seen adjacent to [[yolk sac]] with no visible [[embryo]]) | ||
***Enlarged yolk sac (>7 mm) | ***Enlarged [[yolk sac]] (>7 mm) | ||
***Small gestational sac in relation to the size of the embryo (<5 mm difference between mean sac diameter and CRL) | ***Small [[gestational sac]] in relation to the size of the [[embryo]] (<5 mm difference between mean sac diameter and CRL) | ||
===History and Symptoms=== | ===History and Symptoms=== | ||
*Constitutional symptoms including fever or chills, suggesting septic abortion. | *Constitutional symptoms including [[fever]] or [[chills]], suggesting septic abortion. | ||
*The history should include when was the date of last menstrual period (LMP), estimated length of gestation, bleeding disorders, previous miscarriage | *The history should include when was the date of last menstrual period (LMP), estimated length of [[gestation]], [[bleeding disorders]], previous [[miscarriage]]. | ||
*The | *The symptoms that raise suspicion of abortion are: | ||
**Vaginal bleeding (the volume of bleeding varies) and suprapubic abdominal cramping (especially during passage of gestational tissue), passage of clot is an important sign. | **[[Vaginal bleeding]] (the volume of bleeding varies) and [[Abdominal cramping|suprapubic abdominal cramping]] (especially during passage of gestational tissue), passage of clot is an important sign. | ||
**Loss or reduction of pregnancy symptoms, such as decreased breast tenderness, nausea and vomiting. | **Loss or reduction of [[pregnancy]] symptoms, such as decreased [[Mastalgia|breast tenderness]], [[nausea and vomiting]]. | ||
*Asymptomatic discovered incidentally or on routine ultrasound in early pregnancy. | *Asymptomatic discovered incidentally or on routine [[ultrasound]] in early [[pregnancy]]. | ||
===Physical Examination=== | ===Physical Examination=== | ||
Line 261: | Line 247: | ||
*'''Vital signs''' | *'''Vital signs''' | ||
Depends on the amount of bleeding, if severe the patient will | Depends on the amount of [[bleeding]], if severe, the patient will be [[Hemodynamically unstable|hemodynamically unstable.]] | ||
*'''Pelvic examination''' | *'''Pelvic examination''' | ||
**Bimanual examination to determine the status of cervix and to estimate the gestational age, adnexal tenderness or masses or cervical motion tenderness to exclude ectopic pregnancy. | **Bimanual examination to determine the status of [[cervix]] and to estimate the [[gestational age]], [[adnexal]] [[tenderness]] or masses or [[cervical motion tenderness]] to exclude [[Ectopic pregnancy|ectopic pregnancy.]] | ||
**Speculum examination to see the source and quantity of bleeding and whether bleeding coming from the cervix and an open cervical os | **[[Speculum|Speculum examination]] to see the source and quantity of [[bleeding]] and whether [[bleeding]] coming from the [[cervix]] and an open [[cervical os]]. | ||
**Common physical examination findings of threatened miscarriage include vital signs should be within reference ranges, soft and non tender abdomen, and closed internal cervical os. | **Common [[physical examination]] findings of threatened [[miscarriage]] include vital signs should be within reference ranges, soft and non-tender [[abdomen]], and closed [[Cervical os|internal cervical os]]. | ||
**Common physical examination findings of incomplete miscarriage include enlarged and soft uterus, dilated and effaced cervix, and products of conception may be partially present in the uterus, at the external os, or may be present in the vagina. | **Common [[physical examination]] findings of incomplete [[miscarriage]] include enlarged and soft [[uterus]], dilated and effaced [[cervix]], and products of [[conception]] may be partially present in the [[uterus]], at the [[external os]], or may be present in the [[vagina]]. | ||
**Common physical examination findings of complete miscarriage include closed cervix, and the uterus should be contracted. | **Common [[physical examination]] findings of complete miscarriage include a [[Cervix|closed cervix]], and the [[uterus]] should be contracted. | ||
**Common physical examination findings of missed miscarriage include normal vital signs, the uterus is small for gestational age, absent fetal heart tones on sonogram and closed cervix. | **Common [[physical examination]] findings of missed miscarriage include normal [[vital signs]], the [[uterus]] is small for [[gestational age]], absent fetal [[Heart rate|heart tones]] on [[sonogram]] and [[Cervix|closed cervix]]. | ||
===Laboratory Findings=== | ===Laboratory Findings=== | ||
*Laboratory studies may include the following:<ref name="pmid16217116">{{cite journal| author=Murray H, Baakdah H, Bardell T, Tulandi T| title=Diagnosis and treatment of ectopic pregnancy. | journal=CMAJ | year= 2005 | volume= 173 | issue= 8 | pages= 905-12 | pmid=16217116 | doi=10.1503/cmaj.050222 | pmc=1247706 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=16217116 }}</ref> | *Laboratory studies may include the following:<ref name="pmid16217116">{{cite journal| author=Murray H, Baakdah H, Bardell T, Tulandi T| title=Diagnosis and treatment of ectopic pregnancy. | journal=CMAJ | year= 2005 | volume= 173 | issue= 8 | pages= 905-12 | pmid=16217116 | doi=10.1503/cmaj.050222 | pmc=1247706 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=16217116 }}</ref> | ||
**Urine pregnancy test. | **Urine [[Pregnancy test|pregnancy test.]] | ||
**Complete blood count with differential, hemoglobin and hematocrit. | **[[Complete blood count]] with differential, [[hemoglobin]] and [[hematocrit]]. | ||
**Blood type and Rh factor. | **[[Blood type]] and [[Rh factor|Rh factor.]] | ||
*[[Serum]] [[Human chorionic gonadotropin|hCG]] and [[progesterone]] have limited utility in the [[diagnostic]] evaluation of abortion. In general, the [[diagnosis]] of [[pregnancy loss]] is made by an [[Ultrasound (disambiguation)|ultrasound]] (U/S) once the presence of intrauterine [[gestational sac]] is confirmed.<ref name="pmid16217116" /> | |||
*Serum hCG and progesterone have limited utility in the diagnostic evaluation of abortion. In general, the diagnosis of pregnancy loss made by U/S once the presence of intrauterine gestational sac is confirmed.<ref name="pmid16217116" /> | *An intrauterine [[pregnancy]] may be seen with ([[transvaginal ultrasound]]) (TVUS) at a [[Human chorionic gonadotropin|ß-hCG]] level of 1500-2000 IU/L. However, indeterminate [[pregnancy]] on [[Transvaginal ultrasound|TVUS]] should undergo [[Human chorionic gonadotropin|ß-hCG]] level testing and if [[Human chorionic gonadotropin|ß-hCG]] levels <1500 repeat hCG in 2 days, if [[Human chorionic gonadotropin|ß-hCG]] levels >1500, do [[Transvaginal ultrasound|TVUS]] again.<ref name="pmid16217116" /> | ||
*An intrauterine pregnancy may be seen with TVUS at a ß-hCG level of 1500-2000 IU/L. However, indeterminate pregnancy on TVUS should undergo ß-hCG level testing and | *[[Ultrasound (disambiguation)|U/S]] is the most accurate [[diagnostic]] modality in the confirmation of a viable [[pregnancy]] during the [[First trimester|first trimester.]] | ||
*U/S is the most accurate diagnostic modality in the confirmation of a viable pregnancy during the first trimester. | *An empty [[uterus]] revealed by U/S in a pregnant woman with positive [[beta-hCG]], suggests a very [[Early pregnancy factor|early pregnancy]] < 3 wk, a completed miscarriage, or an [[ectopic pregnancy]].<ref name="pmid16217116" /> | ||
*An empty uterus revealed by U/S in a pregnant woman with positive beta-hCG, suggests a very early pregnancy < 3 wk, a completed miscarriage, or an ectopic pregnancy.<ref name="pmid16217116" /> | |||
===Electrocardiogram=== | ===Electrocardiogram=== | ||
There are no ECG findings associated with abortion. | There are no [[ECG]] findings associated with abortion. | ||
===X-ray=== | ===X-ray=== | ||
There are no x-ray findings associated with abortion. | There are no [[x-ray]] findings associated with abortion. | ||
===Abdominal/ trans-vaginal Ultrasound<ref name="pmid10696563">{{cite journal| author=Helm TN, Wirth PB, Helm KF| title=Inexpensive digital photography in clinical dermatology and dermatologic surgery. | journal=Cutis | year= 2000 | volume= 65 | issue= 2 | pages= 103-6 | pmid=10696563 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=10696563 }}</ref><ref name="pmid1873233X">{{cite journal| author=Schmidt ML, Smith HE, Gamerman S, DiMichele D, Glazer S, Scott JP| title=Prolonged recombinant activated factor VII (rFVIIa) treatment for severe bleeding in a factor-IX-deficient patient with an inhibitor. | journal=Br J Haematol | year= 1991 | volume= 78 | issue= 3 | pages= 460-3 | pmid=1873233X | doi=10.1111/j.1365-2141.1991.tb04468.x | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=1873233 }}</ref>=== | ===Abdominal/ trans-vaginal Ultrasound <ref name="pmid10696563">{{cite journal| author=Helm TN, Wirth PB, Helm KF| title=Inexpensive digital photography in clinical dermatology and dermatologic surgery. | journal=Cutis | year= 2000 | volume= 65 | issue= 2 | pages= 103-6 | pmid=10696563 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=10696563 }}</ref><ref name="pmid1873233X">{{cite journal| author=Schmidt ML, Smith HE, Gamerman S, DiMichele D, Glazer S, Scott JP| title=Prolonged recombinant activated factor VII (rFVIIa) treatment for severe bleeding in a factor-IX-deficient patient with an inhibitor. | journal=Br J Haematol | year= 1991 | volume= 78 | issue= 3 | pages= 460-3 | pmid=1873233X | doi=10.1111/j.1365-2141.1991.tb04468.x | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=1873233 }}</ref>=== | ||
*Findings on an ultrasound suggestive of nonviable pregnancy include gestational sac >25-mm mean sac diameter [ | *Findings on an [[ultrasound]] suggestive of nonviable [[pregnancy]] include [[gestational sac]] >25-mm mean sac diameter on [[Sonogram|transabdominal sonogram]]; >16-mm MSD on endovaginal [[sonogram]] without a detectable [[embryo]], [[embryo]] without a [[heartbeat]], hyperechoic material within the uterine cavity. | ||
*An incomplete miscarriage on | *An incomplete miscarriage on [[ultrasound]] shows [[gestational sac]] misshaped or collapsed, an irregular complex mass within the [[endometrial]] or cervical canal may be present or echogenic material in the endometrial canal. | ||
*A complete miscarriage may demonstrate an empty uterus noted on | *A complete miscarriage may demonstrate an empty [[uterus]] noted on [[transvaginal ultrasound]]. | ||
===CT scan=== | ===CT scan=== | ||
There are no CT scan findings associated with abortion. However, a CT scan may be helpful in the diagnosis of complications like uterine rupture.<ref name="pmid22383917">{{cite journal| author=Themistoklis SN, Chrysovalantis V, Stylianos A, Nikolaos KL, Efthymia A| title=CT Diagnosis of an Abortion-Related Retroperitoneal Space Abscess. | journal=J Clin Med Res | year= 2011 | volume= 3 | issue= 5 | pages= 268-9 | pmid=22383917 | doi=10.4021/jocmr509w | pmc=3279491 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=22383917 }}</ref> | There are no [[CT scan]] findings associated with abortion. However, a [[CT scan]] may be helpful in the [[diagnosis]] of [[complications]] like [[uterine rupture]].<ref name="pmid22383917">{{cite journal| author=Themistoklis SN, Chrysovalantis V, Stylianos A, Nikolaos KL, Efthymia A| title=CT Diagnosis of an Abortion-Related Retroperitoneal Space Abscess. | journal=J Clin Med Res | year= 2011 | volume= 3 | issue= 5 | pages= 268-9 | pmid=22383917 | doi=10.4021/jocmr509w | pmc=3279491 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=22383917 }}</ref> | ||
===MRI=== | ===MRI=== | ||
The use of MRI in maternal emergency obstetric conditions is relatively limited, MRI has a role where USG is indeterminate, particularly in ectopic pregnancy.<ref name="pmid27081223">{{cite journal| author=Gupta R, Bajaj SK, Kumar N, Chandra R, Misra RN, Malik A | display-authors=etal| title=Magnetic resonance imaging - A troubleshooter in obstetric emergencies: A pictorial review. | journal=Indian J Radiol Imaging | year= 2016 | volume= 26 | issue= 1 | pages= 44-51 | pmid=27081223 | doi=10.4103/0971-3026.178292 | pmc=4813073 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=27081223 }}</ref> | The use of a [[MRI]] in maternal emergency obstetric conditions is relatively limited, a [[MRI]] has a role where [[Sonogram|USG]] is indeterminate, particularly in [[ectopic pregnancy]].<ref name="pmid27081223">{{cite journal| author=Gupta R, Bajaj SK, Kumar N, Chandra R, Misra RN, Malik A | display-authors=etal| title=Magnetic resonance imaging - A troubleshooter in obstetric emergencies: A pictorial review. | journal=Indian J Radiol Imaging | year= 2016 | volume= 26 | issue= 1 | pages= 44-51 | pmid=27081223 | doi=10.4103/0971-3026.178292 | pmc=4813073 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=27081223 }}</ref> | ||
===Other Imaging Findings=== | ===Other Imaging Findings=== | ||
There are no other imaging findings associated with abortion. | There are no other [[imaging]] findings associated with abortion. | ||
===Other Diagnostic Studies=== | ===Other Diagnostic Studies=== | ||
There are no other diagnostic studies associated with abortion. | There are no other [[diagnostic]] studies associated with abortion. | ||
==Treatment== | ==Treatment== | ||
===Expectant management=== | |||
*Waiting for [[pregnancy]] tissue to pass recommended only in the [[first trimester]], after 13 weeks, [[medication]] management in a health facility or surgical management should be considered. | |||
*[[Pain management]] in the [[first trimester]] is typically [[Non-steroidal anti-inflammatory drug|nonsteroidal anti-inflammatory drugs]] for [[pain]]. | |||
*Follow-up to confirm complete passage of gestational tissue by [[ultrasound]]. | |||
*Incomplete [[uterine]] emptying still require [[uterine]] aspiration. | |||
*Administer [[Rho(D) Immune Globulin|RhoGAM]] to women with [[Rh incompatibility (patient information)|Rh-negative]] and is experiencing [[vaginal bleeding]] | |||
===Medical Therapy=== | |||
*'''Up to 13 weeks of gestation''':<ref name="pmid29874535">{{cite journal| author=Schreiber CA, Creinin MD, Atrio J, Sonalkar S, Ratcliffe SJ, Barnhart KT| title=Mifepristone Pretreatment for the Medical Management of Early Pregnancy Loss. | journal=N Engl J Med | year= 2018 | volume= 378 | issue= 23 | pages= 2161-2170 | pmid=29874535 | doi=10.1056/NEJMoa1715726 | pmc=6437668 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=29874535 }}</ref><ref name="urlMiscarriage - StatPearls - NCBI Bookshelf4">{{cite web |url=https://www.ncbi.nlm.nih.gov/books/NBK532992/#!po=5.55556 |title=Miscarriage - StatPearls - NCBI Bookshelf |format= |work= |accessdate=}}</ref> | |||
**[[mifepristone]] followed by [[misoprostol]] 24 hours later. | |||
**'''Dose:''' [[mifepristone]] 200 mg orally followed in 24 hours by [[misoprostol]] 800 mcg per [[vagina]] (typically given as four 200 mcg tablets). | |||
**[[Antibiotics]] are not recommended for routine medication management of abortion.<ref name="urlapps.who.int">{{cite web |url=https://apps.who.int/iris/bitstream/handle/10665/70914/9789241548434_eng.pdf?sequence=1 |title=apps.who.int |format= |work= |accessdate=}}</ref> | |||
**[[Pain]] management with [[Non-steroidal anti-inflammatory drug|nonsteroidal anti-inflammatory drug (NSAID)]] prior to using [[misoprostol]].<ref name="urlapps.who.int" /> | |||
**[[Misoprostol]] alone regemin 800 mcg per [[vagina]] (typically four 200 mcg tablets). For patients who do not have complete expulsion after a single dose, a second dose can be given. Between 9 and 12 weeks, the [[World Health Organization|World Health Organization (WHO)]] recommends an initial 800 mcg dose of [[misoprostol]] followed by 400 mcg every three hours until expulsion.<ref name="urlapps.who.int" /> | |||
*'''13 to 20 weeks of gestation''' | |||
**Regardless of the gestational age, medication management of [[pregnancy loss]] includes [[mifepristone]] and [[misoprostol]]. The difference is that the [[misoprostol]] dose is often reduced and repeated, and should be done in a health facility. | |||
[ | {| class="wikitable" | ||
|+Guideline for safe abortion according to [[WHO]]<ref name="urlapps.who.int" /> | |||
! align="center" style="background: #4479BA; color: #FFFFFF " |Recommended methods for medical abortion | |||
|- | |||
|'''The recommended method for medical abortion is [[mifepristone]] followed by [[misoprostol]].''' | |||
|- | |||
|[[Gestational age]] up to 9 weeks the recommended method for medical abortion is [[mifepristone]] followed 1 to 2 days later by [[misoprostol]] | |||
|- | |||
|[[Dosage|Dosages]] and recommendation | |||
*[[Mifepristone]] should always be administered orally. The recommended dose is 200 mg. | |||
*Administration of [[misoprostol]] is recommended 1 to 2 days (24 to 48 hours) following ingestion of [[mifepristone]]. | |||
**For [[vaginal]], [[sublingual]] routes, the recommended dose of [[misoprostol]] is 800 μg. | |||
**For oral administration, the recommended dose of [[misoprostol]] is 400 μg. | |||
**With gestations up to 7 weeks [[misoprostol]] may be administered by [[vaginal]], [[sublingual]] or oral routes. After 7 weeks of [[gestation]], oral administration of [[misoprostol]] should not be used. | |||
**With [[Gestation|gestations]] up to 9 weeks [[misoprostol]] can be administered by [[vaginal]], [[sublingual]] routes. | |||
|- | |||
|'''For [[pregnancies]] of [[gestational age]] between 9 and 12 weeks''' | |||
*The recommended method for medical abortion is 200 mg [[mifepristone]] administered orally followed 36 to 48 hours later by 800 μg [[misoprostol]] administered [[Vaginal|vaginally]]. | |||
*Subsequent [[misoprostol]] doses should be 400 μg, administered either [[Vaginal|vaginally]] or [[Sublingual|sublingually]], every 3 hours up to four further doses, until expulsion of the products of [[conception]]. | |||
|- | |||
|'''For [[pregnancies]] of [[gestational age]] over 12 weeks''' | |||
The recommended method for medical abortion is 200 mg [[mifepristone]] administered orally followed 36 to 48 hours later by repeated doses of [[misoprostol]]. | |||
*[[Gestation|Gestations]] between 12 and 24 weeks, the initial [[misoprostol]] dose following oral [[mifepristone]] administration may be either 800 μg administered [[Vaginal|vaginally]] or 400 μg administered orally. Subsequent [[misoprostol]] doses should be 400 μg, administered either [[Vaginal|vaginally]] or sublingually, every 3 hours up to four further doses. | |||
[ | |||
*For [[pregnancies]] beyond 24 weeks, the dose of [[misoprostol]] should be reduced, due to the greater [[sensitivity]] of the [[uterus]] to [[prostaglandins]], but the lack of [[clinical]] studies precludes specific dosing recommendations. | |||
|} | |||
<br /> | |||
===Surgery=== | ===Surgery=== | ||
*[[Surgery]] evacuation with sharp [[curettage]] or [[suction curettage]] is not the first-line treatment option for [[patients]] with early [[pregnancy loss]]. | |||
*[[Surgery]] is usually reserved for [[patients]] with either [[hemorrhage]], [[hemodynamic instability]], or [[signs]] of [[infection]].<ref name="pmid18053098">{{cite journal| author=Wen J, Cai QY, Deng F, Li YP| title=Manual versus electric vacuum aspiration for first-trimester abortion: a systematic review. | journal=BJOG | year= 2008 | volume= 115 | issue= 1 | pages= 5-13 | pmid=18053098 | doi=10.1111/j.1471-0528.2007.01572.x | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=18053098 }}</ref> | |||
*This is also the preferred method of treatment for women with comorbid [[conditions]] such as [[cardiovascular disease]], [[infection]], [[Anemia|severe anemia]], or [[bleeding]] disorders. | |||
{| class="wikitable" | |||
|+Guideline for safe abortion according to WHO<ref name="urlapps.who.int2">{{cite web |url=https://apps.who.int/iris/bitstream/handle/10665/70914/9789241548434_eng.pdf?sequence=1 |title=apps.who.int |format= |work= |accessdate=}}</ref> | |||
! align="center" style="background: #4479BA; color: #FFFFFF " |Recommended methods of abortion for [[pregnancies]] of [[gestational age]] over 12 to 14 weeks | |||
|- | |||
|[[Dilation and curettage|Dilatation and evacuation]] (D&E) and medical methods ([[mifepristone]] and [[misoprostol]]; [[misoprostol]] alone) are both recommended methods for abortion for gestation over 12 to 14 weeks. Facilities should offer at least one, and preferably both methods, if possible, depending on provider experience and the availability of training. | |||
|} | |||
*[[Antibiotic|Antibiotic prophylaxis]] should be given before surgical [[Evacuation of retained products of conception|evacuation]] | |||
{| class="wikitable" | |||
|+ | |||
! align="center" style="background: #4479BA; color: #FFFFFF " |Guidelines for antibiotic prophylaxis prior uterine evacuation with vacuum aspiration<ref name="urlwww.rcog.org.uk">{{cite web |url=https://www.rcog.org.uk/globalassets/documents/guidelines/best-practice-papers/best-practice-paper-2.pdf |title=www.rcog.org.uk |format= |work= |accessdate=}}</ref> | |||
|- | |||
|'''If there is no suspicion of [[infection]] and [[Uterine|uterine size]] is less than 14 weeks''' | |||
|- | |||
|Antibiotic prophylaxis should be given before [[surgical]] evacuation | |||
*200 mg [[doxycycline]] within 2 hours before the [[procedure]] or | |||
*A single dose of 500 mg [[azithromycin]] within 2 hours before the [[procedure]] | |||
(NB. If [[antibiotics]] are not available, the procedure should not be delayed.) | |||
|- | |||
|'''If there is no suspicion of [[infection]] and [[uterine]] size is 14 weeks or larger''' | |||
*[[Antibiotic]] prophylaxis should be given before [[surgical]] [[Evacuation of retained products of conception|evacuation]] | |||
**200 mg [[doxycycline]] within 2 hours before the [[procedure]] (with or without 200 mg [[doxycycline]] after the abortion) or | |||
**A single dose of 500 mg [[azithromycin]] within 2 hours before the [[procedure]] | |||
|} | |||
===Primary Prevention=== | ===Primary Prevention=== | ||
Effective measures for the primary prevention of unsafe abortion include :<ref name="pmid22883917">{{cite journal| author=Faúndes A| title=Strategies for the prevention of unsafe abortion. | journal=Int J Gynaecol Obstet | year= 2012 | volume= 119 Suppl 1 | issue= | pages= S68-71 | pmid=22883917 | doi=10.1016/j.ijgo.2012.03.021 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=22883917 }}</ref> | Effective measures for the [[primary prevention]] of unsafe abortion include :<ref name="pmid22883917">{{cite journal| author=Faúndes A| title=Strategies for the prevention of unsafe abortion. | journal=Int J Gynaecol Obstet | year= 2012 | volume= 119 Suppl 1 | issue= | pages= S68-71 | pmid=22883917 | doi=10.1016/j.ijgo.2012.03.021 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=22883917 }}</ref> | ||
*Use of contraception has been shown effective decrease in abortion rate. | *Use of [[contraception]] has been shown an effective decrease in the abortion rate. | ||
*Sexual education programs. | *[[Sexual]] [[education]] programs. | ||
*Easy access to contraception. | *Easy access to [[contraception]]. | ||
* | *Social protection to reduce induced abortion among pregnant women who have been abandoned by their partners, rejected by their families. | ||
===Secondary Prevention=== | ===Secondary Prevention=== | ||
The only way to prevent an unsafe abortion is to provide safe services for termination of pregnancy.<ref name="pmid22883917" /> | The only way to prevent an unsafe abortion is to provide safe services for [[termination of pregnancy]].<ref name="pmid22883917" /> | ||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} | ||
[[Category:Primary care]] | |||
[[Category:Obstetrics]] | |||
[[Category:Medicine]] | |||
[[Category:Up-To-Date]] |
Latest revision as of 15:08, 2 April 2021
WikiDoc Resources for Abortion |
Articles |
---|
Most recent articles on Abortion |
Media |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Abortion at Clinical Trials.gov Clinical Trials on Abortion at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Abortion
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Directions to Hospitals Treating Abortion Risk calculators and risk factors for Abortion
|
Healthcare Provider Resources |
Causes & Risk Factors for Abortion |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Nuha Al-Howthi, MD[2]
Synonyms and keywords:Pregnancy loss, miscarriage, spontaneous abortion
Overview
Abortion is the termination of pregnancy before 20 weeks of gestation, which was first described by an ancient Egyptian medical text as the Ebers Papyrus in 1550 BCE. Abortion is classified as threatened, complete, incomplete, inevitable, septic or missed. Chromosomal abnormalities is the most common cause of sporadic abortion that occur as early as 4-8 weeks gestation, or it could be due to either infectious, immunologic, and environmental factors. Fetal causes of abortion are genetic or chromosomal abnormalities while maternal causes include age, antiphospholipid syndrome, severe hypertension, or systemic lupus erythematosus (SLE). Risk factors for abortion include non-modifiable risk factors like advanced age >35 years and previous pregnancy loss. Modifiable risk factors include obesity, infections, acute and chronic stress, medication and substance use, cocaine, alcohol, tobacco and caffeine. Complications of abortion include infection, post abortion traid, uterine perforation, septic abortion, cervical shock, cervical laceration, and disseminated intravascular coagulation (DIC). The prognosis of abortion depends on the gestational age. The younger the gestational age, the lower the risk of complications.
Historical Perspective
- Abortion means termination of a pregnancy and it has been known since ancient times.
- Abortion was first described by an ancient Egyptian medical text as the Ebers Papyrus in 1550 BCE, which suggested that an abortion can be induced with the use of a plant-fiber tampon coated with honey and crushed dates.[1]
- During the ancient Egyptian, Persian, and Roman eras, abortion was practiced although it was never explicitly mentioned in any book of the Judeo-Christian Bible.[1]
- In the fourth century BCE, Niddah 23a, a chapter of the Babylonian Talmud, reviews abortion as determining whether a woman is "unclean" and permitting abortion during early pregnancy.[1]
" A woman can only abort something in the shape of a stone, and that can only be described as a lump."
- In 11th century BCE, the Code of Assura, '' a harsh set of laws restricting women in general'' was the earliest legal ban on abortion by forcing the death penalty on married women who obtain abortions without permission of their husbands.[2]
- In the fifth century BCE, the Hippocratic Oath prohibited physicians from inducing elective abortions.[3]
- In the 19th century, surgical abortions became common and Hegar dilator in 1879 invented dilation-and-curettage (D&C).[4]
- On November 18, 1920, the Commissariats of Health and Justice legalized abortion in Soviet hospitals.[5][6]
- In 1970, Hawaii, New York, Alaska and Washington declared their abortion laws. Hawaii was the first state to legalize abortions and New York allowed abortions up to the 24th week of pregnancy.[7]
Classification
Abortion can be classified into the following:[8] [9][10]
Abortion type | Characteristics |
---|---|
Early Threatened | Abortion before 12 weeks gestation
Symptoms: the variable amount of bleeding Cervix: closed Ultrasound: viable pregnancy |
Late Inevitable | Abortion between 12 and 20 weeks gestation
Symptoms: vaginal bleeding and abdominal pain Cervix:dilated/ open Ultrasound: product of conception seen at or above the cervix. |
Spontaneous | Non-induced abortion |
Missed | Undetected death of an embryo or a fetus that is not expelled and that causes no bleeding (also called a blighted ovum, anembryonic pregnancy, or intrauterine embryonic demise)
Symptoms: variable, asymptomatic, light vaginal bleeding Cervix: closed Ultrasound: Nonviable fetus |
Inevitable | Vaginal bleeding or rupture of the membranes accompanied by dilation of the cervix
Symptoms: Vaginal bleeding, uterine cramps, Cervix: Open Ultrasound: Intrauterine fetus with possible heartbeats, ruptured or collapsed gestational sac |
Incomplete | Expulsion of some products of conception
Symptoms: Vaginal bleeding with large clots or tissue, uterine cramps, some products of conception can be visualized in the dilated cervical os Cervix: Open Ultrasound: products of conception in the cervix |
Threatened | Vaginal bleeding occurring before 20 weeks gestation without cervical dilation and indicating that spontaneous abortion may occur
Symptoms: the variable amount of bleeding Cervix: closed Ultrasound: viable pregnancy |
Septic | Serious infection of the uterine contents during or shortly before or after an abortion. Usually after induced abortion and rarely after spontaneous abortion
Symptoms: fever, malaise, signs of sepsis, foul vaginal discharge, cervical motion tenderness, uterine tenderness, can be life-threatening Cervix: open Ultrasound: retained products of conception |
Complete | Expulsion of all products of conception
Symptoms: variable, asymptomatic Cervix: closed, and the uterus should be contracted. Ultrasound: uterus is empty |
Recurrent or habitual | ≥ 2 to 3 consecutive spontaneous abortions |
Therapeutic | Termination of pregnancy because the woman’s life or health is endangered or because the fetus is dead or has malformations incompatible with life. |
Induced | Termination of pregnancy for medical or elective reasons |
Pathophysiology
- Chromosomal abnormalities is the most common cause of sporadic abortion that occurs as early as 4-8 weeks gestation, for instance aneuploidy, mosaicism, translocation, inversion, deletion, or fragile sites.[11]
- First-trimester pregnancy loss could be due to either infectious, immunologic, and environmental factors.
- Immunologic factors is not well defined. Several theories suggest that early pregnancy loss could be due to: [12][13]
- Allogeneic factors.
- Lack of the immunological protection of the embryos, such as complement regulatory proteins (eg, mannose-binding lectin, and HLA-DR, HLA-G or HLA-E)
- Increased activity of uterine natural killer (uNK) cells.
- Alloimmunization to blood group antigen P.[14]
- Anatomic distortion of uterus may be associated with early or second trimester pregnancy loss, eg: fibroids, polyps, adhesions, or septa depending on the size and position.
- The mechanism of pregnancy loss due to septate uterus is not clearly understood, one theory suggests that poor blood supply to the septum leads to poor implantation.[15]
- FXIII and fibrinogen play an essential role in placental implantation and maintenance of pregnancy, that is why a deficiency of factor XIII (FXIII) and fibrinogen are associated with pregnancy loss.[16]
- It is thought that miscarriage risk is associated with low plasma levels of the hormone kisspeptin.[17]
- The mechanism of abortion in cases of PCOS is unknown, however it could be related to elevated serum luteinizing hormone (LH) levels, high testosterone and androstenedione concentrations or insulin resistance[18]
Causes
- Genetic or chromosomal abnormalities (45,X karyotype, Trisomies (Trisomy 16 is the most common), aneuploidy, mosaicism, translocation, inversion, deletion, fragile sites)
- Teratogenic and mutagenic factors.
- Genetic: Maternal age is directly related to the aneuploidy risk,
- Parental chromosomal anomaly balanced translocation
- Corpus luteum deficiency
- Active infection such as rubella virus, cytomegalovirus
- Antiphospholipid syndrome
- Severe hypertension
- Systemic lupus erythematosus (SLE)
- Renal disease
- Poorly controlled diabetes mellitus
- Polycystic ovary syndrome
Differentiating abortion from other Diseases
Abortion should be differentiated from other causes of bleeding with cramping in early pregnancy:[21]
Epidemiology and Demographics
- The incidence of abortion worldwide was estimated to be 35 per 1,000 women ages 15 to 44 from 2010 to 2014.[22]
- The rate in resource-rich countries was 27 per 1,000 and in resource-limited countries was 37 per 1,000. The incidence was highest in the Caribbean (65 per 1,000), and the lowest in North America (17 per 1,000). [23]
- In the United States, one in four women will have an abortion during their reproductive life.[23]
- The incidence of abortion is approximately 31%, the true incidence of abortion is difficult to ascertain, as many losses are not recognized[24][25]
- The rate of abortion is influenced by maternal age and history of prior pregnancy loss.[26] 15% of women experience sporadic abortion, 2% of pregnant women experience two consecutive abortion and only 0.4 to 1% have three consecutive abortion. [27]
- The incidence of abortions in the United States were highest in women ages 20 to 24 (19.1 per 1,000 women) and 25 to 29 (18.5 per 1,000 women)[28]
- Most abortions were done in women who were unmarried (85%) and had one or more children (59%).[28]
- Abortion rates in individuals of non-Hispanic White were 38.7, 20.0 for Hispanic, and 7.7 for other races per 1,000 women. [28]
- In the United States in 2018, 78% of abortions occur at 9 weeks or earlier, 92% at 13 weeks or earlier, and 8% at or after 14 weeks.[29]
Risk Factors
Non-modifiable risk factors include: [30]
- Advanced age >35 years, the most significant risk factor because of the associated fetal chromosomal abnormalities.
- Extremes of age
- Advanced paternal age
- Previous pregnancy loss increases the risk of later pregnancy loss.[31]
Modifiable risk factors include:
- Obesity[32]
- Infection (eg: Parvovirus B19 infection,syphilis, cytomegalovirus (CMV) infection)[33][34][35]
- Pre-gestational diabetes increases the risk of miscarriage two- to threefold.[36]
- Hyper- and hypothyroidism [37]
- Acute and chronic stress[38]
- Medication and substance use, examples are NSAIDs (ibuprofen and diclofenac), cocaine, methamphetamines[39]
Screening
There is insufficient evidence to recommend routine screening for abortion.
Natural History, Complications, and Prognosis
- Complications of spontaneous abortion and therapeutic abortions include the following:[44]
- Complications of anesthesia
- Post abortion triad (pain, bleeding, low-grade fever) caused by retained products of conception.
- Retained products of conception
- Uterine perforation[45]
- Septic abortion[46]
- Cervical shock
- Cervical laceration
- Disseminated intravascular coagulation (DIC)
- Prognosis of abortion depends on the gestational age. The younger the gestational age, the lower the risk of complications. The highest risk of death is from a septic abortion; the majority of these cases are a result of illegal abortions in developing countries.[47]
Diagnosis
Diagnostic Study of Choice
- Ultrasound shows no intrauterine pregnancy or loss of previously seen cardiac activity is diagnostic if the intrauterine pregnancy is confirmed by ultrasound in a previous visit.[48]
- The diagnosis of early pregnancy loss (EPL) occurs if the initial transvaginal ultrasound shows intrauterine pregnancy without fetal cardiac activity and is based on the criteria made by the Society of Radiologists in Ultrasound Multi-specialty Panel on Early First Trimester Diagnosis of Miscarriage and Exclusion of a Viable Intrauterine Pregnancy, which include:[49]
- A gestational sac ≥25 mm in mean diameter that does not contain a yolk sac or embryo
- An embryo with a crown-rump length (CRL) ≥7 mm that does not have cardiac activity
- After a pelvic ultrasound shows a gestational sac without a yolk sac, absence of an embryo with a heartbeat in ≥2 weeks
- After a pelvic ultrasound shows a gestational sac with a yolk sac, absence of an embryo with a heartbeat in ≥11 days
- Findings that are suspicious for, but not diagnostic of, pregnancy loss include:
- CRL <7 mm and no heartbeat.
- Mean sac diameter of 16 to 24 mm and no embryo.
- Absence of embryo with a heartbeat 7 to 13 days after a scan that showed a gestational sac without a yolk sac
- Absence of embryo with a heartbeat 7 to 10 days after a scan that showed a gestational sac with a yolk sac
- Absence of embryo ≥6 weeks after last menstrual period
- Empty amnion (amnion seen adjacent to yolk sac with no visible embryo)
- Enlarged yolk sac (>7 mm)
- Small gestational sac in relation to the size of the embryo (<5 mm difference between mean sac diameter and CRL)
History and Symptoms
- Constitutional symptoms including fever or chills, suggesting septic abortion.
- The history should include when was the date of last menstrual period (LMP), estimated length of gestation, bleeding disorders, previous miscarriage.
- The symptoms that raise suspicion of abortion are:
- Vaginal bleeding (the volume of bleeding varies) and suprapubic abdominal cramping (especially during passage of gestational tissue), passage of clot is an important sign.
- Loss or reduction of pregnancy symptoms, such as decreased breast tenderness, nausea and vomiting.
- Asymptomatic discovered incidentally or on routine ultrasound in early pregnancy.
Physical Examination
- Vital signs
Depends on the amount of bleeding, if severe, the patient will be hemodynamically unstable.
- Pelvic examination
- Bimanual examination to determine the status of cervix and to estimate the gestational age, adnexal tenderness or masses or cervical motion tenderness to exclude ectopic pregnancy.
- Speculum examination to see the source and quantity of bleeding and whether bleeding coming from the cervix and an open cervical os.
- Common physical examination findings of threatened miscarriage include vital signs should be within reference ranges, soft and non-tender abdomen, and closed internal cervical os.
- Common physical examination findings of incomplete miscarriage include enlarged and soft uterus, dilated and effaced cervix, and products of conception may be partially present in the uterus, at the external os, or may be present in the vagina.
- Common physical examination findings of complete miscarriage include a closed cervix, and the uterus should be contracted.
- Common physical examination findings of missed miscarriage include normal vital signs, the uterus is small for gestational age, absent fetal heart tones on sonogram and closed cervix.
Laboratory Findings
- Laboratory studies may include the following:[50]
- Urine pregnancy test.
- Complete blood count with differential, hemoglobin and hematocrit.
- Blood type and Rh factor.
- Serum hCG and progesterone have limited utility in the diagnostic evaluation of abortion. In general, the diagnosis of pregnancy loss is made by an ultrasound (U/S) once the presence of intrauterine gestational sac is confirmed.[50]
- An intrauterine pregnancy may be seen with (transvaginal ultrasound) (TVUS) at a ß-hCG level of 1500-2000 IU/L. However, indeterminate pregnancy on TVUS should undergo ß-hCG level testing and if ß-hCG levels <1500 repeat hCG in 2 days, if ß-hCG levels >1500, do TVUS again.[50]
- U/S is the most accurate diagnostic modality in the confirmation of a viable pregnancy during the first trimester.
- An empty uterus revealed by U/S in a pregnant woman with positive beta-hCG, suggests a very early pregnancy < 3 wk, a completed miscarriage, or an ectopic pregnancy.[50]
Electrocardiogram
There are no ECG findings associated with abortion.
X-ray
There are no x-ray findings associated with abortion.
Abdominal/ trans-vaginal Ultrasound [51][52]
- Findings on an ultrasound suggestive of nonviable pregnancy include gestational sac >25-mm mean sac diameter on transabdominal sonogram; >16-mm MSD on endovaginal sonogram without a detectable embryo, embryo without a heartbeat, hyperechoic material within the uterine cavity.
- An incomplete miscarriage on ultrasound shows gestational sac misshaped or collapsed, an irregular complex mass within the endometrial or cervical canal may be present or echogenic material in the endometrial canal.
- A complete miscarriage may demonstrate an empty uterus noted on transvaginal ultrasound.
CT scan
There are no CT scan findings associated with abortion. However, a CT scan may be helpful in the diagnosis of complications like uterine rupture.[53]
MRI
The use of a MRI in maternal emergency obstetric conditions is relatively limited, a MRI has a role where USG is indeterminate, particularly in ectopic pregnancy.[54]
Other Imaging Findings
There are no other imaging findings associated with abortion.
Other Diagnostic Studies
There are no other diagnostic studies associated with abortion.
Treatment
Expectant management
- Waiting for pregnancy tissue to pass recommended only in the first trimester, after 13 weeks, medication management in a health facility or surgical management should be considered.
- Pain management in the first trimester is typically nonsteroidal anti-inflammatory drugs for pain.
- Follow-up to confirm complete passage of gestational tissue by ultrasound.
- Incomplete uterine emptying still require uterine aspiration.
- Administer RhoGAM to women with Rh-negative and is experiencing vaginal bleeding
Medical Therapy
- Up to 13 weeks of gestation:[55][56]
- mifepristone followed by misoprostol 24 hours later.
- Dose: mifepristone 200 mg orally followed in 24 hours by misoprostol 800 mcg per vagina (typically given as four 200 mcg tablets).
- Antibiotics are not recommended for routine medication management of abortion.[57]
- Pain management with nonsteroidal anti-inflammatory drug (NSAID) prior to using misoprostol.[57]
- Misoprostol alone regemin 800 mcg per vagina (typically four 200 mcg tablets). For patients who do not have complete expulsion after a single dose, a second dose can be given. Between 9 and 12 weeks, the World Health Organization (WHO) recommends an initial 800 mcg dose of misoprostol followed by 400 mcg every three hours until expulsion.[57]
- 13 to 20 weeks of gestation
- Regardless of the gestational age, medication management of pregnancy loss includes mifepristone and misoprostol. The difference is that the misoprostol dose is often reduced and repeated, and should be done in a health facility.
Recommended methods for medical abortion |
---|
The recommended method for medical abortion is mifepristone followed by misoprostol. |
Gestational age up to 9 weeks the recommended method for medical abortion is mifepristone followed 1 to 2 days later by misoprostol |
Dosages and recommendation
|
For pregnancies of gestational age between 9 and 12 weeks
|
For pregnancies of gestational age over 12 weeks
The recommended method for medical abortion is 200 mg mifepristone administered orally followed 36 to 48 hours later by repeated doses of misoprostol.
|
Surgery
- Surgery evacuation with sharp curettage or suction curettage is not the first-line treatment option for patients with early pregnancy loss.
- Surgery is usually reserved for patients with either hemorrhage, hemodynamic instability, or signs of infection.[58]
- This is also the preferred method of treatment for women with comorbid conditions such as cardiovascular disease, infection, severe anemia, or bleeding disorders.
Recommended methods of abortion for pregnancies of gestational age over 12 to 14 weeks |
---|
Dilatation and evacuation (D&E) and medical methods (mifepristone and misoprostol; misoprostol alone) are both recommended methods for abortion for gestation over 12 to 14 weeks. Facilities should offer at least one, and preferably both methods, if possible, depending on provider experience and the availability of training. |
- Antibiotic prophylaxis should be given before surgical evacuation
Guidelines for antibiotic prophylaxis prior uterine evacuation with vacuum aspiration[60] |
---|
If there is no suspicion of infection and uterine size is less than 14 weeks |
Antibiotic prophylaxis should be given before surgical evacuation
(NB. If antibiotics are not available, the procedure should not be delayed.) |
If there is no suspicion of infection and uterine size is 14 weeks or larger
|
Primary Prevention
Effective measures for the primary prevention of unsafe abortion include :[61]
- Use of contraception has been shown an effective decrease in the abortion rate.
- Sexual education programs.
- Easy access to contraception.
- Social protection to reduce induced abortion among pregnant women who have been abandoned by their partners, rejected by their families.
Secondary Prevention
The only way to prevent an unsafe abortion is to provide safe services for termination of pregnancy.[61]
References
- ↑ 1.0 1.1 1.2 "The Ancient History of Abortion and When it Began".
- ↑ "Internet History Sourcebooks".
- ↑ "The Hippocratic Oath in Roe v. Wade | by Tara Mulder | EIDOLON".
- ↑ "The Ancient History of Abortion and When it Began".
- ↑ Endres, Richard J. (1971). "Abortion in perspective". American Journal of Obstetrics and Gynecology. 111 (3): 436–439. doi:10.1016/0002-9378(71)90791-5. ISSN 0002-9378.
- ↑ Rushton DI (1978). "Simplified classification of spontaneous abortions". J Med Genet. 15 (1): 1–9. doi:10.1136/jmg.15.1.1. PMC 1012814. PMID 564967.
- ↑ Ganatra B, Gerdts C, Rossier C, Johnson BR, Tunçalp Ö, Assifi A; et al. (2017). "Global, regional, and subregional classification of abortions by safety, 2010-14: estimates from a Bayesian hierarchical model". Lancet. 390 (10110): 2372–2381. doi:10.1016/S0140-6736(17)31794-4. PMC 5711001. PMID 28964589.
- ↑ Fujikura T, Froehlich LA, Driscoll SG (1966). "A simplified anatomic classification of abortions". Am J Obstet Gynecol. 95 (7): 902–5. doi:10.1016/0002-9378(66)90537-0. PMID 5914126.
- ↑ Stephenson MD, Awartani KA, Robinson WP (2002). "Cytogenetic analysis of miscarriages from couples with recurrent miscarriage: a case-control study". Hum Reprod. 17 (2): 446–51. doi:10.1093/humrep/17.2.446. PMID 11821293.
- ↑ Kallen CB, Arici A (2003). "Immune testing in fertility practice: truth or deception?". Curr Opin Obstet Gynecol. 15 (3): 225–31. doi:10.1097/00001703-200306000-00003. PMID 12858110.
- ↑ Hill JA, Choi BC (2000). "Maternal immunological aspects of pregnancy success and failure". J Reprod Fertil Suppl. 55: 91–7. PMID 10889838.
- ↑ Hanafusa N, Noiri E, Yamashita T, Kondo Y, Suzuki M, Watanabe Y; et al. (2006). "Successful treatment by double filtrate plasmapheresis in a pregnant woman with the rare P blood group and a history of multiple early miscarriages". Ther Apher Dial. 10 (6): 498–503. doi:10.1111/j.1744-9987.2006.00393.x. PMID 17199881.
- ↑ Homer HA, Li TC, Cooke ID (2000). "The septate uterus: a review of management and reproductive outcome". Fertil Steril. 73 (1): 1–14. doi:10.1016/s0015-0282(99)00480-x. PMID 10632403.
- ↑ Inbal A, Muszbek L (2003). "Coagulation factor deficiencies and pregnancy loss". Semin Thromb Hemost. 29 (2): 171–4. doi:10.1055/s-2003-38832. PMID 12709920.
- ↑ Jayasena CN, Abbara A, Izzi-Engbeaya C, Comninos AN, Harvey RA, Gonzalez Maffe J; et al. (2014). "Reduced levels of plasma kisspeptin during the antenatal booking visit are associated with increased risk of miscarriage". J Clin Endocrinol Metab. 99 (12): E2652–60. doi:10.1210/jc.2014-1953. PMC 4255122. PMID 25127195.
- ↑ Craig LB, Ke RW, Kutteh WH (2002). "Increased prevalence of insulin resistance in women with a history of recurrent pregnancy loss". Fertil Steril. 78 (3): 487–90. doi:10.1016/s0015-0282(02)03247-8. PMID 12215322.
- ↑ Pereza N, Ostojić S, Kapović M, Peterlin B (2017). "Systematic review and meta-analysis of genetic association studies in idiopathic recurrent spontaneous abortion". Fertil Steril. 107 (1): 150–159.e2. doi:10.1016/j.fertnstert.2016.10.007. PMID 27842992.
- ↑ Barut MU, Bozkurt M, Kahraman M, Yıldırım E, Imirzalioğlu N, Kubar A; et al. (2018). "Thrombophilia and Recurrent Pregnancy Loss: The Enigma Continues". Med Sci Monit. 24: 4288–4294. doi:10.12659/MSM.908832. PMC 6045916. PMID 29932168.
- ↑ "Miscarriage - StatPearls - NCBI Bookshelf".
- ↑ Sedgh G, Bearak J, Singh S, Bankole A, Popinchalk A, Ganatra B; et al. (2016). "Abortion incidence between 1990 and 2014: global, regional, and subregional levels and trends". Lancet. 388 (10041): 258–67. doi:10.1016/S0140-6736(16)30380-4. PMC 5498988. PMID 27179755.
- ↑ 23.0 23.1 Jones RK, Jerman J (2017). "Abortion Incidence and Service Availability In the United States, 2014". Perspect Sex Reprod Health. 49 (1): 17–27. doi:10.1363/psrh.12015. PMC 5487028. PMID 28094905.
- ↑ Magnus MC, Wilcox AJ, Morken NH, Weinberg CR, Håberg SE (2019). "Role of maternal age and pregnancy history in risk of miscarriage: prospective register based study". BMJ. 364: l869. doi:10.1136/bmj.l869. PMC 6425455. PMID 30894356.
- ↑ Wilcox AJ, Weinberg CR, O'Connor JF, Baird DD, Schlatterer JP, Canfield RE; et al. (1988). "Incidence of early loss of pregnancy". N Engl J Med. 319 (4): 189–94. doi:10.1056/NEJM198807283190401. PMID 3393170.
- ↑ Magnus MC, Wilcox AJ, Morken NH, Weinberg CR, Håberg SE (2019). "Role of maternal age and pregnancy history in risk of miscarriage: prospective register based study". BMJ. 364: l869. doi:10.1136/bmj.l869. PMC 6425455. PMID 30894356.
- ↑ Salat-Baroux J (1988). "[Recurrent spontaneous abortions]". Reprod Nutr Dev. 28 (6B): 1555–68. PMID 3073445.
- ↑ 28.0 28.1 28.2 Kortsmit K, Jatlaoui TC, Mandel MG, Reeves JA, Oduyebo T, Petersen E; et al. (2020). "Abortion Surveillance - United States, 2018". MMWR Surveill Summ. 69 (7): 1–29. doi:10.15585/mmwr.ss6907a1. PMC 7713711 Check
|pmc=
value (help). PMID 33237897 Check|pmid=
value (help). - ↑ Kortsmit K, Jatlaoui TC, Mandel MG, Reeves JA, Oduyebo T, Petersen E; et al. (2020). "Abortion Surveillance - United States, 2018". MMWR Surveill Summ. 69 (7): 1–29. doi:10.15585/mmwr.ss6907a1. PMC 7713711 Check
|pmc=
value (help). PMID 33237897 Check|pmid=
value (help). - ↑ Hu X, Miao M, Bai Y, Cheng N, Ren X (2018). "Reproductive Factors and Risk of Spontaneous Abortion in the Jinchang Cohort". Int J Environ Res Public Health. 15 (11). doi:10.3390/ijerph15112444. PMC 6266092. PMID 30400160.
- ↑ Magnus MC, Wilcox AJ, Morken NH, Weinberg CR, Håberg SE (2019). "Role of maternal age and pregnancy history in risk of miscarriage: prospective register based study". BMJ. 364: l869. doi:10.1136/bmj.l869. PMC 6425455. PMID 30894356.
- ↑ Metwally M, Ong KJ, Ledger WL, Li TC (2008). "Does high body mass index increase the risk of miscarriage after spontaneous and assisted conception? A meta-analysis of the evidence". Fertil Steril. 90 (3): 714–26. doi:10.1016/j.fertnstert.2007.07.1290. PMID 18068166.
- ↑ Frazier T, Hogue CJR, Bonney EA, Yount KM, Pearce BD (2018). "Weathering the storm; a review of pre-pregnancy stress and risk of spontaneous abortion". Psychoneuroendocrinology. 92: 142–154. doi:10.1016/j.psyneuen.2018.03.001. PMID 29628283.
- ↑ Rasti S, Ghasemi FS, Abdoli A, Piroozmand A, Mousavi SG, Fakhrie-Kashan Z (2016). "ToRCH "co-infections" are associated with increased risk of abortion in pregnant women". Congenit Anom (Kyoto). 56 (2): 73–8. doi:10.1111/cga.12138. PMID 26499091.
- ↑ Gomez GB, Kamb ML, Newman LM, Mark J, Broutet N, Hawkes SJ (2013). "Untreated maternal syphilis and adverse outcomes of pregnancy: a systematic review and meta-analysis". Bull World Health Organ. 91 (3): 217–26. doi:10.2471/BLT.12.107623. PMC 3590617. PMID 23476094.
- ↑ Tennant PW, Glinianaia SV, Bilous RW, Rankin J, Bell R (2014). "Pre-existing diabetes, maternal glycated haemoglobin, and the risks of fetal and infant death: a population-based study". Diabetologia. 57 (2): 285–94. doi:10.1007/s00125-013-3108-5. PMID 24292565.
- ↑ Maraka S, Ospina NM, O'Keeffe DT, Espinosa De Ycaza AE, Gionfriddo MR, Erwin PJ; et al. (2016). "Subclinical Hypothyroidism in Pregnancy: A Systematic Review and Meta-Analysis". Thyroid. 26 (4): 580–90. doi:10.1089/thy.2015.0418. PMC 4827301. PMID 26837268.
- ↑ Li Y, Margerison-Zilko C, Strutz KL, Holzman C (2018). "Life Course Adversity and Prior Miscarriage in a Pregnancy Cohort". Womens Health Issues. 28 (3): 232–238. doi:10.1016/j.whi.2018.02.001. PMID 29530382.
- ↑ Nakhai-Pour HR, Broy P, Sheehy O, Bérard A (2011). "Use of nonaspirin nonsteroidal anti-inflammatory drugs during pregnancy and the risk of spontaneous abortion". CMAJ. 183 (15): 1713–20. doi:10.1503/cmaj.110454. PMC 3193112. PMID 21896698. Review in: Evid Based Nurs. 2012 Jul;15(3):76-7
- ↑ Avalos LA, Roberts SC, Kaskutas LA, Block G, Li DK (2014). "Volume and type of alcohol during early pregnancy and the risk of miscarriage". Subst Use Misuse. 49 (11): 1437–45. doi:10.3109/10826084.2014.912228. PMC 4183196. PMID 24810392.
- ↑ Ness RB, Grisso JA, Hirschinger N, Markovic N, Shaw LM, Day NL; et al. (1999). "Cocaine and tobacco use and the risk of spontaneous abortion". N Engl J Med. 340 (5): 333–9. doi:10.1056/NEJM199902043400501. PMID 9929522.
- ↑ Chen LW, Wu Y, Neelakantan N, Chong MF, Pan A, van Dam RM (2016). "Maternal caffeine intake during pregnancy and risk of pregnancy loss: a categorical and dose-response meta-analysis of prospective studies". Public Health Nutr. 19 (7): 1233–44. doi:10.1017/S1368980015002463. PMID 26329421.
- ↑ Lee SW, Han YJ, Cho DH, Kwak HS, Ko K, Park MH; et al. (2018). "Smoking Exposure in Early Pregnancy and Adverse Pregnancy Outcomes: Usefulness of Urinary Tobacco-Specific Nitrosamine Metabolite 4-(Methylnitrosamino)-1-(3-Pyridyl)-1-Butanol Levels". Gynecol Obstet Invest. 83 (4): 365–374. doi:10.1159/000485617. PMID 29739005.
- ↑ Lim LM, Singh K (2014). "Termination of pregnancy and unsafe abortion". Best Pract Res Clin Obstet Gynaecol. 28 (6): 859–69. doi:10.1016/j.bpobgyn.2014.05.005. PMID 24962349.
- ↑ Koshiba A, Koshiba H, Noguchi T, Iwasaku K, Kitawaki J (2012). "Uterine perforation with omentum incarceration after dilatation and evacuation/curettage: magnetic resonance imaging findings". Arch Gynecol Obstet. 285 (3): 887–90. doi:10.1007/s00404-011-2127-z. PMID 22048784.
- ↑ Saultes TA, Devita D, Heiner JD (2009). "The back alley revisited: sepsis after attempted self-induced abortion". West J Emerg Med. 10 (4): 278–80. PMC 2791734. PMID 20046250.
- ↑ "Miscarriage - StatPearls - NCBI Bookshelf".
- ↑ "UpToDate".
- ↑ Doubilet PM, Benson CB, Bourne T, Blaivas M, Society of Radiologists in Ultrasound Multispecialty Panel on Early First Trimester Diagnosis of Miscarriage and Exclusion of a Viable Intrauterine Pregnancy. Barnhart KT; et al. (2013). "Diagnostic criteria for nonviable pregnancy early in the first trimester". N Engl J Med. 369 (15): 1443–51. doi:10.1056/NEJMra1302417. PMID 24106937.
- ↑ 50.0 50.1 50.2 50.3 Murray H, Baakdah H, Bardell T, Tulandi T (2005). "Diagnosis and treatment of ectopic pregnancy". CMAJ. 173 (8): 905–12. doi:10.1503/cmaj.050222. PMC 1247706. PMID 16217116.
- ↑ Helm TN, Wirth PB, Helm KF (2000). "Inexpensive digital photography in clinical dermatology and dermatologic surgery". Cutis. 65 (2): 103–6. PMID 10696563.
- ↑ Schmidt ML, Smith HE, Gamerman S, DiMichele D, Glazer S, Scott JP (1991). "Prolonged recombinant activated factor VII (rFVIIa) treatment for severe bleeding in a factor-IX-deficient patient with an inhibitor". Br J Haematol. 78 (3): 460–3. doi:10.1111/j.1365-2141.1991.tb04468.x. PMID 1873233X Check
|pmid=
value (help). - ↑ Themistoklis SN, Chrysovalantis V, Stylianos A, Nikolaos KL, Efthymia A (2011). "CT Diagnosis of an Abortion-Related Retroperitoneal Space Abscess". J Clin Med Res. 3 (5): 268–9. doi:10.4021/jocmr509w. PMC 3279491. PMID 22383917.
- ↑ Gupta R, Bajaj SK, Kumar N, Chandra R, Misra RN, Malik A; et al. (2016). "Magnetic resonance imaging - A troubleshooter in obstetric emergencies: A pictorial review". Indian J Radiol Imaging. 26 (1): 44–51. doi:10.4103/0971-3026.178292. PMC 4813073. PMID 27081223.
- ↑ Schreiber CA, Creinin MD, Atrio J, Sonalkar S, Ratcliffe SJ, Barnhart KT (2018). "Mifepristone Pretreatment for the Medical Management of Early Pregnancy Loss". N Engl J Med. 378 (23): 2161–2170. doi:10.1056/NEJMoa1715726. PMC 6437668. PMID 29874535.
- ↑ "Miscarriage - StatPearls - NCBI Bookshelf".
- ↑ 57.0 57.1 57.2 57.3 "apps.who.int" (PDF).
- ↑ Wen J, Cai QY, Deng F, Li YP (2008). "Manual versus electric vacuum aspiration for first-trimester abortion: a systematic review". BJOG. 115 (1): 5–13. doi:10.1111/j.1471-0528.2007.01572.x. PMID 18053098.
- ↑ "apps.who.int" (PDF).
- ↑ "www.rcog.org.uk" (PDF).
- ↑ 61.0 61.1 Faúndes A (2012). "Strategies for the prevention of unsafe abortion". Int J Gynaecol Obstet. 119 Suppl 1: S68–71. doi:10.1016/j.ijgo.2012.03.021. PMID 22883917.